Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
J Infect Dis
    February 2021
  1. VUJKOVIC-CVIJIN I, Sortino O, Verheij E, Wit FW, et al
    The complement pathway is activated in people with HIV and is associated with non-AIDS comorbidities.
    J Infect Dis. 2021 Feb 19. pii: 6144980. doi: 10.1093.
    >> Share

  2. CHUAYPEN N, Jinato T, Avihingsanon A, Chirapongsathorn S, et al
    Improvement of Gut Diversity and Composition after Direct-Acting Antivirals in HCV-Infected Patients with or without HIV Coinfection.
    J Infect Dis. 2021 Feb 17. pii: 6141513. doi: 10.1093.
    >> Share

  3. BANHART S, Selb R, Oehlmann S, Bender J, et al
    The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae, Germany, 2018.
    J Infect Dis. 2021 Feb 16. pii: 6138844. doi: 10.1093.
    >> Share

  4. LI C, Mori L, Valente ST
    The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A.
    J Infect Dis. 2021;223.
    >> Share

  5. SILICIANO JD, Siliciano RF
    Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
    J Infect Dis. 2021;223.
    >> Share

  6. LI JZ, Gandhi RT
    The Search for an HIV Cure: Where Do We Go From Here?
    J Infect Dis. 2021;223.
    >> Share

  7. LI Y, Mohammadi A, Li JZ
    Challenges and Promise of Human Immunodeficiency Virus Remission.
    J Infect Dis. 2021;223.
    >> Share

  8. ROSSIGNOL E, Alter G, Julg B
    Antibodies for Human Immunodeficiency Virus-1 Cure Strategies.
    J Infect Dis. 2021;223.
    >> Share

  9. KASEKE C, Tano-Menka R, Senjobe F, Gaiha GD, et al
    The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.
    J Infect Dis. 2021;223.
    >> Share

  10. ZHOU Y, Maldini CR, Jadlowsky J, Riley JL, et al
    Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy.
    J Infect Dis. 2021;223.
    >> Share

  11. CHITNENI P, Matthews LT
    The Other U=U. Untested and Untreated genital tract inflammation in people living with and exposed to HIV.
    J Infect Dis. 2021 Feb 10. pii: 6131968. doi: 10.1093.
    >> Share

  12. WALL KM, Karita E, Nyombayire J, Ingabire R, et al
    Genital abnormalities, hormonal contraception, and HIV transmission risk in Rwandan serodifferent couples.
    J Infect Dis. 2021 Feb 9. pii: 6131738. doi: 10.1093.
    >> Share

  13. RON R, Cabello A, Gosalbes MJ, Sanchez-Conde M, et al
    Exploiting the Microbiota for the Diagnosis of Anal Precancerous Lesions in Men Who Have Sex With Men.
    J Infect Dis. 2021 Feb 5. pii: 6129308. doi: 10.1093.
    >> Share

    January 2021
  14. PARK SY, Faraci G, Murphy G, Pilcher C, et al
    Microdrop HIV sequencing for incidence and drug resistance surveillance.
    J Infect Dis. 2021 Jan 31. pii: 6124747. doi: 10.1093.
    >> Share

  15. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    >> Share

  16. EATON EF, Clement ME
    Wave the Yellow Flag: Why we should prioritize routine HIV and STI care now.
    J Infect Dis. 2021 Jan 27. pii: 6121541. doi: 10.1093.
    >> Share

  17. MASTRO TD, Bateganya M, Mahler H
    The need to optimize HIV test and treat in Africa.
    J Infect Dis. 2021 Jan 21. pii: 6104550. doi: 10.1093.
    >> Share

  18. GRABOWSKI MK, Patel EU, Nakigozi G, Ssempijja V, et al
    Prevalence and predictors of persistent HIV viremia and viral rebound following universal test and treat: a population-based study.
    J Infect Dis. 2021 Jan 20. pii: 6104546. doi: 10.1093.
    >> Share

  19. ROUTY JP, Isnard S
    Beyond the absence of CD4 T-cell count: A novel genetic CD4 T-cell deficiency disorder with a contingency plan.
    J Infect Dis. 2021 Jan 18. pii: 6103163. doi: 10.1093.
    >> Share

  20. STEIN CM, Benchek P, Bartlett J, Igo RP, et al
    Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa.
    J Infect Dis. 2021 Jan 5. pii: 6064776. doi: 10.1093.
    >> Share

  21. PILAROWSKI G, Lebel P, Sunshine S, Liu J, et al
    Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco.
    J Infect Dis. 2021 Jan 4. pii: 6061974. doi: 10.1093.
    >> Share

  22. MALTEZOU HC, Raftopoulos V, Vorou R, Papadima K, et al
    Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection.
    J Infect Dis. 2021 Jan 3. pii: 6060070. doi: 10.1093.
    >> Share

  23. GAISA MM, Sigel KM, Deshmukh AA, Lenskaya V, et al
    Comparing Anal Cancer Screening Algorithms Using Cytology and HPV DNA Testing in Three High-risk Populations.
    J Infect Dis. 2021 Jan 3. pii: 6060069. doi: 10.1093.
    >> Share

    December 2020
  24. JANKOWSKI CM, Wilson MP, MaWhinney S, Reusch J, et al
    Blunted muscle mitochondrial responses to exercise training in older adults with HIV.
    J Infect Dis. 2020 Dec 30. pii: 6055584. doi: 10.1093.
    >> Share

  25. KROEZE S, Rossouw TM, Steel HC, Wit FW, et al
    Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy.
    J Infect Dis. 2020 Dec 29. pii: 6054994. doi: 10.1093.
    >> Share

  26. RAWAT P, Brummel SS, Singh KK, Kim J, et al
    Genomics Links Inflammation with Neurocognitive Impairment in Children Living with Human Immunodeficiency Virus type-1.
    J Infect Dis. 2020 Dec 29. pii: 6054995. doi: 10.1093.
    >> Share

  27. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years.
    J Infect Dis. 2020 Dec 26. pii: 6053002. doi: 10.1093.
    >> Share

  28. SORTINO O, Dias J, Anderson M, Laidlaw E, et al
    Preserved MAIT cell numbers and function in idiopathic CD4 lymphocytopenia.
    J Infect Dis. 2020 Dec 25. pii: 6047591. doi: 10.1093.
    >> Share

  29. HEARPS AC, Angelovich TA, Trevillyan JM, Wong ME, et al
    Rosuvastatin therapy in people with HIV at intermediate cardiovascular risk does not decrease biomarkers of inflammation and immune activation.
    J Infect Dis. 2020 Dec 22. pii: 6044066. doi: 10.1093.
    >> Share

  30. MCMAHON DK, Zheng L, Cyktor JC, Aga E, et al
    A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).
    J Infect Dis. 2020 Dec 22. pii: 6043307. doi: 10.1093.
    >> Share

  31. MANION M, Dulanto Chiang A, Pei L, Wong CS, et al
    Disseminated Mycobacterium marinum in HIV unmasked by Immune Reconstitution Inflammatory Syndrome.
    J Infect Dis. 2020 Dec 18. pii: 6041190. doi: 10.1093.
    >> Share

  32. KIRKEGAARD-KLITBO DM, Bendtsen F, Lundgren J, de Knegt RJ, et al
    Increased prevalence of liver fibrosis in people living with HIV without viral hepatitis compared to population controls.
    J Infect Dis. 2020 Dec 15. pii: 6035145. doi: 10.1093.
    >> Share

  33. JIANG W, Luo Z, Stephenson S, Li H, et al
    Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury.
    J Infect Dis. 2020 Dec 15. pii: 6035152. doi: 10.1093.
    >> Share

  34. SUNDERMANN EE, Bondi MW, Campbell LM, Gouaux B, et al
    Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders.
    J Infect Dis. 2020 Dec 15. pii: 6034152. doi: 10.1093.
    >> Share

  35. MARTIN AR, Bender AM, Hackman J, Kwon KJ, et al
    Similar frequency and inducibility of intact HIV-1 proviruses in blood and lymph nodes.
    J Infect Dis. 2020 Dec 3. pii: 6017470. doi: 10.1093.
    >> Share

    November 2020
  36. JEYARAJAN AJ, Chung RT
    Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?
    J Infect Dis. 2020;222.
    >> Share

  37. ROCKSTROH JK, Boesecke C
    Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men.
    J Infect Dis. 2020;222.
    >> Share

  38. POYNTEN IM, Jin F, Garland SM, Hillman RJ, et al
    HIV, immune dysfunction and the natural history of anal high-risk human papillomavirus infection in gay and bisexual men.
    J Infect Dis. 2020 Nov 21. pii: 5998258. doi: 10.1093.
    >> Share

  39. FALCINELLI SD, Kilpatrick KW, Read J, Murtagh R, et al
    Longitudinal dynamics of intact HIV proviral DNA and outgrowth virus frequencies in a cohort of ART-treated individuals.
    J Infect Dis. 2020 Nov 20. pii: 5995716. doi: 10.1093.
    >> Share

  40. MEYER-MYKLESTAD MH, Medhus AW, Lorvik KB, Seljeflot I, et al
    HIV-infected immunological non-responders have colon-restricted gut mucosal immune dysfunction.
    J Infect Dis. 2020 Nov 20. pii: 5995605. doi: 10.1093.
    >> Share

  41. BERTAGNOLIO S, Hermans L, Jordan MR, Avila-Rios S, et al
    Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
    J Infect Dis. 2020 Nov 17. pii: 5986606. doi: 10.1093.
    >> Share

  42. DEESE J, Wang M, Lapple D, Nelson JAE, et al
    What's sex got to do with it? Understanding potential confounding and exposure misclassification in mechanistic sexually transmitted infection research.
    J Infect Dis. 2020 Nov 12. pii: 5974974. doi: 10.1093.
    >> Share

  43. DIETRICH LG, Thorball CW, Ryom L, Burkhalter F, et al
    Rapid Progression of Kidney Dysfunction in Swiss People Living with HIV: Contribution of Polygenic Risk Score and D:A:D Clinical Risk Score.
    J Infect Dis. 2020 Nov 5. pii: 5957071. doi: 10.1093.
    >> Share

  44. HALEY DF, Edmonds A, Ramirez C, French AL, et al
    Direct-acting antiviral Hepatitis C treatment cascade and barriers to treatment initiation among US men and women with and without HIV.
    J Infect Dis. 2020 Nov 3. pii: 5952700. doi: 10.1093.
    >> Share

    October 2020
  45. LUONG NGUYEN LB, Freedberg KA, Wanjala S, Maman D, et al
    Comparative effectiveness of interventions to improve the HIV continuum of care and HIV Pre-Exposure Prophylaxis in Kenya: a model-based analysis.
    J Infect Dis. 2020 Oct 27. pii: 5940739. doi: 10.1093.
    >> Share

  46. BREGLIO KF, Vinhaes CL, Arriaga MB, Nason M, et al
    Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with HIV.
    J Infect Dis. 2020 Oct 26. pii: 5940424. doi: 10.1093.
    >> Share

  47. DONOVAN J, Tram TTB, Phu NH, Hiep NTT, et al
    The influence of Strongyloides stercoralis co-infection on the presentation, pathogenesis and outcome of tuberculous meningitis.
    J Infect Dis. 2020 Oct 26. pii: 5940016. doi: 10.1093.
    >> Share

  48. MINAB R, Bu W, Nguyen H, Wall A, et al
    Maternal Epstein-Barr virus-specific antibodies and risk of infection in Ugandan infants.
    J Infect Dis. 2020 Oct 23. pii: 5936635. doi: 10.1093.
    >> Share

  49. DAVY-MENDEZ T, Napravnik S, Hogan BC, Althoff KN, et al
    Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015.
    J Infect Dis. 2020 Oct 21. pii: 5934541. doi: 10.1093.
    >> Share

  50. OLSON A, Coote C, Snyder-Cappione JE, Lin N, et al
    HIV-1 transcription but not intact provirus levels are associated with systemic inflammation.
    J Infect Dis. 2020 Oct 19. pii: 5930820. doi: 10.1093.
    >> Share

  51. YOSHIKAWA S, Yoshio S, Yoshida Y, Tsutsui Y, et al
    Impact of Immune Reconstitution-induced Hepatic Flare on HBsAg Loss in HBV/HIV-1-Coinfected Patients.
    J Infect Dis. 2020 Oct 19. pii: 5929874. doi: 10.1093.
    >> Share

  52. FICHTENBAUM CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, et al
    Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
    J Infect Dis. 2020 Oct 17. pii: 5928646. doi: 10.1093.
    >> Share

  53. SLYKER JA, Guthrie B, Pankau M, Tapia K, et al
    Cytomegalovirus and Epstein-Barr virus viremia are associated with HIV DNA levels in the reservoir of Kenyan infants on antiretroviral therapy.
    J Infect Dis. 2020 Oct 16. pii: 5926738. doi: 10.1093.
    >> Share

  54. IKEUCHI K, Adachi E, Sasaki T, Suzuki M, et al
    An outbreak of USA300 MRSA among people with HIV in Japan.
    J Infect Dis. 2020 Oct 15. pii: 5923726. doi: 10.1093.
    >> Share

  55. TIRABOSCHI JM, Rojas J, Zetterberg H, Blennow K, et al
    No changes in HIV suppression and inflammatory markers in CSF in patients randomly switched to DTG + 3TC (Spanish HIV/AIDS Research Network, PreEC/RIS 62).
    J Infect Dis. 2020 Oct 13. pii: 5922599. doi: 10.1093.
    >> Share

  56. LUSCOMBE CA, Avihingsanon A, Supparatpinyo K, Gatechompol S, et al
    Human immunodeficiency virus type-1 Vpu inhibitor, BIT225, in combination with 3-drug antiretroviral therapy modulates inflammation and immune cells functions.
    J Infect Dis. 2020 Oct 10. pii: 5920638. doi: 10.1093.
    >> Share

  57. KIRK GD, Astemborski J, Mehta SH, Ritter KD, et al
    Non-structured treatment interruptions are associated with higher HIV reservoir size measured by intact proviral DNA assay in people who inject drugs.
    J Infect Dis. 2020 Oct 10. pii: 5920557. doi: 10.1093.
    >> Share

    September 2020
  58. THUDIUM RF, Knudsen AD, Stemann JHV, Hove-Skovsgaard M, et al
    Independent Association of Interleukin 6 With Low Dynamic Lung Function and Airflow Limitation in Well-Treated People With Human Immunodeficiency Virus.
    J Infect Dis. 2020 Sep 24. pii: 5910961. doi: 10.1093.
    >> Share

  59. YANG CX, Schon E, Obeidat M, Kobor MS, et al
    Accelerated Epigenetic Aging and Methylation Disruptions Occur in Human Immunodeficiency Virus Infection Prior to Antiretroviral Therapy.
    J Infect Dis. 2020 Sep 22. pii: 5909822. doi: 10.1093.
    >> Share

  60. SCHNITTMAN SR, Deitchman AN, Beck-Engeser G, Ahn H, et al
    Some But Not All Biomarkers of Immune Activation Remain Abnormal Despite Very Early Treatment of HIV.
    J Infect Dis. 2020 Sep 11. pii: 5904261. doi: 10.1093.
    >> Share

  61. MALONEY KM, Le Guillou A, Driggers RA, Sarkar S, et al
    Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral HIV Pre-Exposure Prophylaxis: A Mathematical Model.
    J Infect Dis. 2020 Sep 3. pii: 5901097. doi: 10.1093.
    >> Share

  62. COHEN MS, Landovitz R
    Assessing the Role of Long Acting Cabotegravir Pre-Exposure Prophylaxis of HIV: Opportunities and Aspirations.
    J Infect Dis. 2020 Sep 3. pii: 5901096. doi: 10.1093.
    >> Share

  63. SPRINGER SA, Barocas JA, Wurcel A, Nijhawan A, et al
    Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy Agenda.
    J Infect Dis. 2020;222.
    >> Share

  64. JORDAN AE, Cleland CM, Wyka K, Schackman BR, et al
    Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.
    J Infect Dis. 2020;222.
    >> Share

  65. ROWAN SE, Kamis KF, Beum R, Bryan K, et al
    Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
    J Infect Dis. 2020;222.
    >> Share

  66. GORBACH PM, Javanbakht M, Ragsdale A, Bolan RB, et al
    Methamphetamine Injection Among Young Men Who Have Sex With Men: Risk for Human Immunodeficiency Virus Transmission in a Los Angeles Cohort.
    J Infect Dis. 2020;222.
    >> Share

  67. JORDAN AE, Cleland CM, Schackman BR, Wyka K, et al
    Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.
    J Infect Dis. 2020;222.
    >> Share

  68. TUMPNEY M, John B, Panneer N, McClung RP, et al
    Human Immunodeficiency Virus (HIV) Outbreak Investigation Among Persons Who Inject Drugs in Massachusetts Enhanced by HIV Sequence Data.
    J Infect Dis. 2020;222.
    >> Share

  69. ASSOUMOU SA, Paniagua SM, Linas BP, Wang J, et al
    Rapid Versus Laboratory-Based Testing for HIV and Hepatitis C at a Drug Detoxification Treatment Center: A Randomized Trial.
    J Infect Dis. 2020;222.
    >> Share

  70. RAO S, Song W, Mulatu MS, Seena E, et al
    Human Immunodeficiency Virus Testing, Diagnosis, Linkage to Care, and Prevention Services Among Persons Who Inject Drugs, United States, 2012-2017.
    J Infect Dis. 2020;222.
    >> Share

  71. ADAMS M, Sionean C, Broz D, Lewis R, et al
    Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use.
    J Infect Dis. 2020;222.
    >> Share

  72. ALLEN ST, Grieb SM, White RH, O'Rourke A, et al
    Human Immunodeficiency Virus Testing Among People Who Inject Drugs in Rural West Virginia.
    J Infect Dis. 2020;222.
    >> Share

  73. KIM MM, Conyngham SC, Smith C, Higgins D, et al
    Understanding the Intersection of Behavioral Risk and Social Determinants of Health and the Impact on an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs in Philadelphia.
    J Infect Dis. 2020;222.
    >> Share

  74. LEWIS R, Baugher AR, Finlayson T, Wejnert C, et al
    Healthcare Access and Utilization Among Persons Who Inject Drugs in Medicaid Expansion and Nonexpansion States: 22 United States Cities, 2018.
    J Infect Dis. 2020;222.
    >> Share

  75. WESNER CA, Zhang W, Melstad S, Ruen E, et al
    Assessing County-Level Vulnerability for Opioid Overdose and Rapid Spread of Human Immunodeficiency Virus and Hepatitis C Infection in South Dakota.
    J Infect Dis. 2020;222.
    >> Share

  76. KREBS E, Zang X, Enns B, Min JE, et al
    Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.
    J Infect Dis. 2020;222.
    >> Share

  77. METCALFE R, Ragonnet-Cronin M, Bradley-Stewart A, McAuley A, et al
    From Hospital to the Community: Redesigning the Human Immunodeficiency Virus (HIV) Clinical Service Model to Respond to an Outbreak of HIV Among People Who Inject Drugs.
    J Infect Dis. 2020;222.
    >> Share

  78. LYSS SB, Buchacz K, McClung RP, Asher A, et al
    Responding to Outbreaks of Human Immunodeficiency Virus Among Persons Who Inject Drugs-United States, 2016-2019: Perspectives on Recent Experience and Lessons Learned.
    J Infect Dis. 2020;222.
    >> Share

  79. WINETSKY D, Burack D, Antoniou P, Garcia B, et al
    Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program.
    J Infect Dis. 2020;222.
    >> Share

  80. KRSAK M, Montague BT, Trowbridge P, Johnson SC, et al
    Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications.
    J Infect Dis. 2020;222.
    >> Share

  81. JOHNSON WD, Rivadeneira N, Adegbite AH, Neumann MS, et al
    Human Immunodeficiency Virus Prevention for People Who Use Drugs: Overview of Reviews and the ICOS of PICOS.
    J Infect Dis. 2020;222.
    >> Share

  82. LEVITT A, Mermin J, Jones CM, See I, et al
    Infectious Diseases and Injection Drug Use: Public Health Burden and Response.
    J Infect Dis. 2020;222.
    >> Share

  83. CHAVIS NS, Klein PW, Cohen SM, Dempsey A, et al
    The Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS Program's Response to the Opioid Epidemic.
    J Infect Dis. 2020;222.
    >> Share

  84. RENO H, Fox B, Highfill C, McKee A, et al
    The Emerging Intersection Between Injection Drug Use and Early Syphilis in Nonurban Areas of Missouri, 2012-2018.
    J Infect Dis. 2020;222.
    >> Share

    August 2020
  85. PINANA JL, Xhaard A, Tridello G, Passweg J, et al
    Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation.
    J Infect Dis. 2020 Aug 29. pii: 5899001. doi: 10.1093.
    >> Share

  86. TAKAHASHI S, Greenhouse B, Rodriguez-Barraquer I
    Are SARS-CoV-2 seroprevalence estimates biased?
    J Infect Dis. 2020 Aug 28. pii: 5898481. doi: 10.1093.
    >> Share

  87. TESSEMA SK, Hathaway NJ, Teyssier NB, Murphy M, et al
    Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome.
    J Infect Dis. 2020 Aug 25. pii: 5897005. doi: 10.1093.
    >> Share

  88. GANDHI RT, Cyktor JC, Bosch RJ, Mar H, et al
    Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
    J Infect Dis. 2020 Aug 21. pii: 5895496. doi: 10.1093.
    >> Share

  89. MEHTA SD, Nandi D, Agingu W, Green SJ, et al
    Vaginal and Penile Microbiome Associations with HSV-2 in Women and their Male Sex Partners.
    J Infect Dis. 2020 Aug 21. pii: 5895495. doi: 10.1093.
    >> Share

  90. EDFELDT G, Lajoie J, Rohl M, Oyugi J, et al
    Regular use of depot medroxyprogesterone acetate causes thinning of the superficial lining and apical distribution of HIV target cells in the human ectocervix.
    J Infect Dis. 2020 Aug 11. pii: 5891260. doi: 10.1093.
    >> Share

  91. ERLANDSON KM, Wilson MP, MaWhinney S, Rapaport E, et al
    The Impact of Moderate or High-Intensity Combined Exercise on Systemic Inflammation among Older Persons with and without HIV.
    J Infect Dis. 2020 Aug 11. pii: 5890849. doi: 10.1093.
    >> Share

  92. NYAWANDA BO, Otieno NA, Otieno MO, Emukule GO, et al
    The impact of maternal HIV infection on the burden of respiratory syncytial virus among pregnant women and their infants, western Kenya.
    J Infect Dis. 2020 Aug 10. pii: 5890656. doi: 10.1093.
    >> Share

  93. VINHAES CL, Sheikh V, de-Souza DO, Wang J, et al
    An inflammatory composite score predicts mycobacterial IRIS in people with HIV and severe lymphopenia: A prospective international cohort study.
    J Infect Dis. 2020 Aug 6. pii: 5881925. doi: 10.1093.
    >> Share

    July 2020
  94. MACIAS GIL R, Marcelin JR, Zuniga-Blanco B, Marquez C, et al
    COVID-19 Pandemic: Disparate Health Impact on the Hispanic/Latinx Population in the United States.
    J Infect Dis. 2020 Jul 30. pii: 5878913. doi: 10.1093.
    >> Share

  95. MAFFEI VJ, Siggins RW, Luo M, Brashear MM, et al
    Alcohol Use Is Associated with Intestinal Dysbiosis and Dysfunctional CD8+ T-Cell Phenotypes in Persons with HIV.
    J Infect Dis. 2020 Jul 29. pii: 5877912. doi: 10.1093.
    >> Share

  96. CATLETT B, Bajis S, Starr M, Dore GJ, et al
    Evaluation of the Aptima HCV Quant Dx Assay for HCV RNA detection from finger-stick capillary dried blood spot and venepuncture-collected samples.
    J Infect Dis. 2020 Jul 25. pii: 5876378. doi: 10.1093.
    >> Share

  97. CHAZOT R, Botelho-Nevers E, Mariat C, Fresard A, et al
    Cystatin C and urine albumin-to-creatinine ratio predict 5-year mortality and cardiovascular events in People Living with HIV independently of measured GFR.
    J Infect Dis. 2020 Jul 21. pii: 5874276. doi: 10.1093.
    >> Share

  98. ZHOU S, Sizemore S, Moeser M, Zimmerman S, et al
    Near Real-Time Identification of Recent HIV Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by MPID-NGS in North Carolina.
    J Infect Dis. 2020 Jul 14. pii: 5871442. doi: 10.1093.
    >> Share

  99. OVERTON ET, Kantor A, Fitch KV, Muntner P, et al
    An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.
    J Infect Dis. 2020;222.
    >> Share

  100. UMBLEJA T, Brown TT, Overton ET, Ribaudo HJ, et al
    Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE.
    J Infect Dis. 2020;222.
    >> Share

  101. FICHTENBAUM CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, et al
    Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
    J Infect Dis. 2020;222.
    >> Share

  102. GRINSPOON SK, Douglas PS, Hoffmann U, Ribaudo HJ, et al
    Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators.
    J Infect Dis. 2020;222.
    >> Share

  103. SMEATON LM, Kileel EM, Grinsztejn B, Gardner EM, et al
    Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
    J Infect Dis. 2020;222.
    >> Share

  104. ZANNI MV, Currier JS, Kantor A, Smeaton L, et al
    Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.
    J Infect Dis. 2020;222.
    >> Share

  105. NEILAN TG, Nguyen KL, Zaha VG, Chew KW, et al
    Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.
    J Infect Dis. 2020;222.
    >> Share

  106. RICH SN, Poschman K, Hu H, Mavian C, et al
    Sociodemographic, ecological, and spatiotemporal factors associated with HIV drug resistance in Florida: a retrospective analysis.
    J Infect Dis. 2020 Jul 9. pii: 5869388. doi: 10.1093.
    >> Share

  107. RYOM L, Lundgren JD, Reiss P, Ross M, et al
    The impact of immunosuppression on chronic kidney disease in people living with HIV; the D:A:D study.
    J Infect Dis. 2020 Jul 8. pii: 5868947. doi: 10.1093.
    >> Share

  108. AJAYKUMAR A, Zhu M, Kakkar F, Brophy J, et al
    Blood mitochondrial DNA levels remain elevated from birth to early life in children HIV-exposed uninfected exposed to combination antiretroviral therapy in utero.
    J Infect Dis. 2020 Jul 8. pii: 5868548. doi: 10.1093.
    >> Share

  109. FRANCESCHINI E, De Biasi S, Digaetano M, Bianchini E, et al
    Efficient T cell compartment in HIV+ patients receiving orthotopic liver transplant and immunosuppressive therapy.
    J Infect Dis. 2020 Jul 4. pii: 5867164. doi: 10.1093.
    >> Share

  110. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
    Extent of in-utero transfer of tenofovir from mother to fetus: a paired analysis of hair specimens collected at birth from a cohort in the United States.
    J Infect Dis. 2020 Jul 4. pii: 5867166. doi: 10.1093.
    >> Share

  111. VETTER BN, Reipold EI, Ongarello S, Audu R, et al
    Sensitivity and specificity of rapid diagnostic tests for hepatitis C virus with or without HIV coinfection: a multicentre laboratory evaluation study.
    J Infect Dis. 2020 Jul 2. pii: 5866494. doi: 10.1093.
    >> Share

    June 2020
  112. MAHOMED S, Garrett N, Baxter C, Abdool Karim Q, et al
    Clinical trials of broadly neutralizing monoclonal antibodies for HIV Prevention: A Review.
    J Infect Dis. 2020 Jun 30. pii: 5865449. doi: 10.1093.
    >> Share

  113. CYKTOR JC, Bosch RJ, Mar H, Macatangay BJ, et al
    Male sex and obesity are associated with residual plasma HIV-1 viremia in persons on long-term antiretroviral therapy.
    J Infect Dis. 2020 Jun 30. pii: 5865316. doi: 10.1093.
    >> Share

  114. POVEDA E, Tabernilla A, Fitzgerald W, Salgado-Barreira A, et al
    Massive release of CD9+ microvesicles in HIV infection, regardless of virologic control.
    J Infect Dis. 2020 Jun 30. pii: 5865258. doi: 10.1093.
    >> Share

  115. HO HE, Peluso MJ, Margus C, Matias Lopes JP, et al
    Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV.
    J Infect Dis. 2020 Jun 30. pii: 5864898. doi: 10.1093.
    >> Share

  116. SERRANO-VILLAR S, Sanchez-Carrillo S, Talavera-Rodriguez A, Lelouvier B, et al
    Blood Bacterial Profiles Associated with HIV Infection and Immune Recovery.
    J Infect Dis. 2020 Jun 30. pii: 5864897. doi: 10.1093.
    >> Share

  117. KINLOCH NN, Ritchie G, Brumme CJ, Dong W, et al
    Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results.
    J Infect Dis. 2020 Jun 28. pii: 5864227. doi: 10.1093.
    >> Share

  118. BYAKWAGA H, Barbachano-Guerrero A, Wang D, McAllister S, et al
    Immunoglobulin E (IgE) Levels are associated with Kaposi's Sarcoma in HIV-Infected African Adults.
    J Infect Dis. 2020 Jun 19. pii: 5860159. doi: 10.1093.
    >> Share

  119. WAGNER AD, Kinuthia J, Dettinger J, Mwongeli N, et al
    Challenges of discrepant HIV tests in pregnant women in the PrEP era - to treat or not to treat?
    J Infect Dis. 2020 Jun 19. pii: 5860162. doi: 10.1093.
    >> Share

  120. KNUDSEN AD, Ronit A, Kristensen T, Thomsen MT, et al
    Pulmonary arterial enlargement in well-treated persons with HIV.
    J Infect Dis. 2020 Jun 19. pii: 5860158. doi: 10.1093.
    >> Share

  121. BARROSO LF
    The Natural History of Anal Dysplasia: Unwrapping the Riddle to Find an Enigma.
    J Infect Dis. 2020;222:7-8.
    >> Share

  122. KINGERY JR, Goyal P, Hosalli R, Lee MH, et al
    HIV-Associated Myocardial Diastolic Dysfunction and Soluble ST2 Concentration in Tanzanian Adults: A Cross-Sectional Study.
    J Infect Dis. 2020 Jun 11. pii: 5856147. doi: 10.1093.
    >> Share

  123. DAWSON L, Benbow N, Fletcher FE, Kassaye S, et al
    Addressing ethical challenges in US-based HIV phylogenetic research.
    J Infect Dis. 2020 Jun 11. pii: 5856131. doi: 10.1093.
    >> Share

  124. LAPLANA M, Bravo MJ, Fernandez-Fuertes M, Ruiz-Garcia C, et al
    Toll Like Receptor 2 promoter -196 to -174 deletion affects CD4 levels along HIV infection progression.
    J Infect Dis. 2020 Jun 9. pii: 5855175. doi: 10.1093.
    >> Share

  125. NAGGIE S, Lusk S, Thompson JW, Mock M, et al
    Metabolomic signature as a predictor of liver disease events in patients with HIV/HCV co-infection.
    J Infect Dis. 2020 Jun 5. pii: 5851922. doi: 10.1093.
    >> Share

  126. FALCINELLI SD, Shook-Sa BE, Dewey MG, Sridhar S, et al
    Impact of biological sex on immune activation and frequency of the latent HIV reservoir during suppressive antiretroviral therapy.
    J Infect Dis. 2020 Jun 4. pii: 5851386. doi: 10.1093.
    >> Share

  127. JILG N, Garcia-Broncano P, Peluso M, Segal FP, et al
    Hiv Controllers Maintain Viral Suppression Despite Waning T-Cell Responses On Art.
    J Infect Dis. 2020 Jun 4. pii: 5851400. doi: 10.1093.
    >> Share

  128. SMITH JA, Garnett GP, Hallett TB
    The potential impact of long-acting cabotegravir for HIV prevention in South Africa: a mathematical modelling study.
    J Infect Dis. 2020 Jun 3. pii: 5850980. doi: 10.1093.
    >> Share

  129. NOVITSKY V, Zahralban-Steele M, Moyo S, Nkhisang T, et al
    Mapping of HIV-1C Transmission Networks Reveals Extensive Spread of Viral Lineages across Villages in Botswana Treatment-as-Prevention Trial.
    J Infect Dis. 2020 Jun 3. pii: 5850911. doi: 10.1093.
    >> Share

    May 2020
  130. POPPE LK, Kankasa C, Wood C, West JT, et al
    Relationships between maternal antibody responses and early childhood infection with KSHV.
    J Infect Dis. 2020 May 27. pii: 5847779. doi: 10.1093.
    >> Share

  131. SNELLER MC, Huiting ED, Clarridge KE, Seamon C, et al
    Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy.
    J Infect Dis. 2020 May 22. pii: 5842227. doi: 10.1093.
    >> Share

  132. GOSHU BA, Chen H, Moussa M, Cheng J, et al
    Combination rhIL-15 and anti-PD-L1 (Avelumab) enhances HIVGag-specific CD8 T cell function.
    J Infect Dis. 2020 May 20. pii: 5841297. doi: 10.1093.
    >> Share

  133. STOFFELS K, Vanroye F, Mortier V, Debaisieux L, et al
    Chronic and early antiretroviral therapy impact HIV serological assay sensitivity leading to more false negative test results in HIV diagnosis.
    J Infect Dis. 2020 May 20. pii: 5841310. doi: 10.1093.
    >> Share

  134. KIRKEGAARD-KLITBO DM, Fuchs A, Stender S, Sigvardsen PE, et al
    Prevalence and Risk Factors of Moderate to Severe Hepatic Steatosis in HIV Infection: The Copenhagen Co-Morbidity Liver Study.
    J Infect Dis. 2020 May 16. pii: 5838262. doi: 10.1093.
    >> Share

  135. HE X, Eddy JJ, Jacobson KR, Henderson AJ, et al
    Enhanced HIV-1 Replication in CD4+ T Cells Derived from Individuals with Latent Mycobacterium tuberculosis Infection.
    J Infect Dis. 2020 May 16. pii: 5838261. doi: 10.1093.
    >> Share

  136. ANTHONY DD, Sulkowski MS, Smeaton LM, Damjanovska S, et al
    HCV DAA Therapy in Persons with HIV-HCV Genotype 1 Coinfection Results in High Rate of Sustained Virologic Response and Heterogeneity in Normalization of Soluble Markers of Immune Activation.
    J Infect Dis. 2020 May 15. pii: 5836999. doi: 10.1093.
    >> Share

  137. ROTH JA, Radevski G, Marzolini C, Rauch A, et al
    Cohort-derived machine learning models for individual prediction of chronic kidney disease in people living with HIV: a prospective multicentre cohort study.
    J Infect Dis. 2020 May 9. pii: 5835004. doi: 10.1093.
    >> Share

    April 2020
  138. DEFILIPPI C, Toribio M, Wong LP, Sadreyev R, et al
    Differential Plasma Protein Regulation and Statin Effects in HIV-infected and Non-HIV-infected Patients Utilizing a Proteomics Approach Protein Regulation and Statin Effects in HIV.
    J Infect Dis. 2020 Apr 20. pii: 5822753. doi: 10.1093.
    >> Share

  139. JOHANSEN MD, Kremer L
    A zebrafish model of Mycobacterium kansasii infection reveals large extracellular cord formation.
    J Infect Dis. 2020 Apr 17. pii: 5821259. doi: 10.1093.
    >> Share

  140. JARY A, Leducq V, Desire N, Petit H, et al
    New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies.
    J Infect Dis. 2020 Apr 13. pii: 5819613. doi: 10.1093.
    >> Share

  141. BULL M, Mitchell C, Soria J, Styrchak S, et al
    Genital shedding of human immunodeficiency virus type-1 (HIV) when antiretroviral therapy (ART) suppresses HIV replication in the plasma.
    J Infect Dis. 2020 Apr 10. pii: 5818585. doi: 10.1093.
    >> Share

  142. MELLIEZ H, Mary-Krause M, Guiguet M, Carrieri P, et al
    Risk of severe bacterial infection in people living with HIV infection in the cART era.
    J Infect Dis. 2020 Apr 7. pii: 5816760. doi: 10.1093.
    >> Share

  143. KRAHN T, Martel M, Sapir-Pichhadze R, Kronfli N, et al
    Non-alcoholic fatty liver disease predicts development of metabolic comorbidities in HIV-infected patients.
    J Infect Dis. 2020 Apr 6. pii: 5816366. doi: 10.1093.
    >> Share

  144. KUO HH, Banga R, Lee GQ, Gao C, et al
    Blood and lymph node dissemination of clonal genome-intact HIV-1 DNA sequences during suppressive antiretroviral therapy.
    J Infect Dis. 2020 Apr 1. pii: 5814310. doi: 10.1093.
    >> Share

    March 2020
  145. ALLI BY, Burk RD, Fatahzadeh M, Grossberg RM, et al
    HIV modifies the effect of tobacco smoking on oral human papillomavirus infection.
    J Infect Dis. 2020 Mar 25. pii: 5811439. doi: 10.1093.
    >> Share

  146. BALAGOPAL A, Smeaton LM, Quinn J, Venuto CS, et al
    Intrahepatic Viral Kinetics during Direct-Acting Antivirals for Hepatitis C in HIV Co-infection:The ACTG A5335S Substudy.
    J Infect Dis. 2020 Mar 23. pii: 5810960. doi: 10.1093.
    >> Share

  147. SURIAL B, Ledergerber B, Calmy A, Cavassini M, et al
    Changes in renal function after switching from TDF to TAF in HIV-infected individuals: a prospective cohort study.
    J Infect Dis. 2020 Mar 19. pii: 5809951. doi: 10.1093.
    >> Share

  148. SUN B, Abadjian L, Monto A, Freasier H, et al
    HCV cure in HIV coinfection dampens inflammation and improves cognition through multiple mechanisms.
    J Infect Dis. 2020 Mar 11. pii: 5802775. doi: 10.1093.
    >> Share

  149. MUKERJI SS, Misra V, Lorenz DR, Chettimada S, et al
    Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.
    J Infect Dis. 2020 Mar 10. pii: 5802682. doi: 10.1093.
    >> Share

  150. STONE M, Rosenbloom D, Bacchetti P, Deng X, et al
    Assessing suitability of next-generation viral outgrowth assays as proxies for classic QVOA to measure HIV-1 latent reservoir size.
    J Infect Dis. 2020 Mar 9. pii: 5799268. doi: 10.1093.
    >> Share

  151. ACOSTA E, Bowlin T, Brooks J, Chiang L, et al
    Advances in the Development of Therapeutics for Cytomegalovirus Infections.
    J Infect Dis. 2020;221.
    >> Share

  152. DOBARD C, Makarova N, Nishiura K, Dinh C, et al
    Cabotegravir long-acting protects macaques against repeated penile SHIV exposures.
    J Infect Dis. 2020 Mar 4. pii: 5780064. doi: 10.1093.
    >> Share

    February 2020
  153. COSTA C, Scabini S, Kaimal A, Kasozi W, et al
    Calcaneal quantitative ultrasound and urine retinol binding protein in HIV-positive antiretroviral-treated patients in Uganda: a pilot study.
    J Infect Dis. 2020 Feb 28. pii: 5766432. doi: 10.1093.
    >> Share

  154. BAILIN SS, McGinnis KA, McDonnell WJ, So-Armah K, et al
    T Lymphocyte Subsets Associated with Prevalent Diabetes in Veterans with and without HIV.
    J Infect Dis. 2020 Feb 13. pii: 5734988. doi: 10.1093.
    >> Share

  155. MURENZI G, Kanyabwisha F, Murangwa A, Kubwimana G, et al
    Twelve-year trend in the prevalence of high-risk human papillomavirus infection among Rwandan women living with HIV.
    J Infect Dis. 2020 Feb 12. pii: 5734756. doi: 10.1093.
    >> Share

  156. LO MK, Spengler JR, Krumpe LRH, Welch SR, et al
    Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge.
    J Infect Dis. 2020 Feb 10. pii: 5731546. doi: 10.1093.
    >> Share

  157. KNUDSEN AD, Krebs-Demmer L, Bjorge NID, Elming MB, et al
    Pericardial adipose tissue volume is independently associated with HIV status and prior use of stavudine, didanosine or indinavir.
    J Infect Dis. 2020 Feb 6. pii: 5728662. doi: 10.1093.
    >> Share

    January 2020
  158. VERBOEKET SO, Wit FW, Verheij E, van Zoest RA, et al
    HIV-negative Men Who Have Sex with Men have higher CD8+ T-cell Counts and Lower CD4+/CD8+ T-cell Ratios compared to HIV-negative Heterosexual Men.
    J Infect Dis. 2020 Jan 31. pii: 5718997. doi: 10.1093.
    >> Share

  159. CLICK ES, Kurbatova E, Alexander H, Dalton TL, et al
    Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion.
    J Infect Dis. 2020 Jan 31. pii: 5718252. doi: 10.1093.
    >> Share

  160. RONIT A, Benfield T, Lundgren J, Vestbo J, et al
    Interstitial lung abnormalities in people with HIV infection and uninfected controls.
    J Infect Dis. 2020 Jan 31. pii: 5718248. doi: 10.1093.
    >> Share

  161. LINAS BP
    Time for a New Approach to Guidance for HIV and HCV Testing Among Persons Who Inject Drugs.
    J Infect Dis. 2020 Jan 30. pii: 5718241. doi: 10.1093.
    >> Share

  162. BULL-OTTERSON L, Huang YA, Zhu W, King H, et al
    HIV and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017.
    J Infect Dis. 2020 Jan 30. pii: 5718242. doi: 10.1093.
    >> Share

  163. GREBELY J, Catlett B, Jayasinghe I, Valerio H, et al
    Time to detection of hepatitis C virus infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a more rapid time to diagnosis.
    J Infect Dis. 2020 Jan 29. pii: 5717213. doi: 10.1093.
    >> Share

  164. TZOU PL, Descamps D, Rhee SY, Raugi DN, et al
    Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.
    J Infect Dis. 2020 Jan 22. pii: 5713448. doi: 10.1093.
    >> Share

  165. DEZANET LNC, Maylin S, Gabassi A, Rougier H, et al
    Kinetics of hepatitis B core-related antigen and anti-hepatitis B core antibody and their association with serological response in HIV-hepatitis B co-infection.
    J Infect Dis. 2020 Jan 21. pii: 5710864. doi: 10.1093.
    >> Share

  166. MCMAHON JH, Hoy JF
    Frailty, the next obstacle for People with HIV to achieve Healthy Ageing.
    J Infect Dis. 2020 Jan 20. pii: 5709702. doi: 10.1093.
    >> Share

  167. VERHEIJ E, Kirk GD, Wit FW, van Zoest RA, et al
    Frailty is associated with mortality and incident comorbidity among middle-aged HIV-positive and HIV-negative participants.
    J Infect Dis. 2020 Jan 20. pii: 5709696. doi: 10.1093.
    >> Share

  168. CLIPMAN SJ, Duggal P, Srikrishnan AK, Saravanan S, et al
    Prevalence and phylogenetic characterization of hepatitis C among men who have sex with men in India: limited evidence for sexual transmission.
    J Infect Dis. 2020 Jan 9. pii: 5699640. doi: 10.1093.
    >> Share

    December 2019
  169. NILSSON A, Chiodi F
    Early antiretroviral therapy may preserve vaccine responses in HIV infected patients by preventing damage to long-lived plasma cells.
    J Infect Dis. 2019 Dec 23. pii: 5684907. doi: 10.1093.
    >> Share

  170. THOMAS A, Hammarlund E, Gao L, Holman S, et al
    Loss of Pre-Existing Immunological Memory among HIV Infected Women Despite Immune Reconstitution with Antiretroviral Therapy.
    J Infect Dis. 2019 Dec 23. pii: 5684906. doi: 10.1093.
    >> Share

  171. REICHLER MR, Bruden D, Thomas H, Erickson BR, et al
    Ebola Patient Virus Cycle Threshold and Risk of Household Transmission of Ebola Virus.
    J Infect Dis. 2019 Dec 19. pii: 5681532. doi: 10.1093.
    >> Share

  172. PHILLIPS A, Cambiano V, Johnson L, Nakagawa F, et al
    Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in KwaZulu-Natal accounting for drug resistance.
    J Infect Dis. 2019 Dec 18. pii: 5680588. doi: 10.1093.
    >> Share

  173. ZHANG T, Wilson IB, Youn B, Lee Y, et al
    Factors Associated with ART Re-Initiation in Medicaid Recipients with HIV.
    J Infect Dis. 2019 Dec 16. pii: 5678130. doi: 10.1093.
    >> Share

  174. WIJERS JNAP, Dukers-Muijrers NHTM, van Liere GAFS, Dirks JAMC, et al
    Men and women have an equal oropharyngeal and anorectal Chlamydia trachomatis bacterial load: a comparison of three anatomic sites.
    J Infect Dis. 2019 Dec 16. pii: 5678512. doi: 10.1093.
    >> Share

  175. COSTAGLIOLA D, Potard V, Lang S, De Castro N, et al
    Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.
    J Infect Dis. 2019 Dec 11. pii: 5673542. doi: 10.1093.
    >> Share

  176. TRIANT VA, Siedner MJ
    Darunavir and Cardiovascular Risk: Evaluating the Data to Inform Clinical Care.
    J Infect Dis. 2019 Dec 11. pii: 5673540. doi: 10.1093.
    >> Share

  177. MBUNKAH HA, Bertagnolio S, Hamers RL, Hunt G, et al
    Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: A systematic review of detection methods, prevalence, and clinical impact.
    J Infect Dis. 2019 Dec 6. pii: 5664819. doi: 10.1093.
    >> Share

  178. ANDERSON JL, Khoury G, Fromentin R, Solomon A, et al
    Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy.
    J Infect Dis. 2019 Dec 4. pii: 5651233. doi: 10.1093.
    >> Share

    November 2019
  179. TIRABOSCHI J, Imaz A, Khoo S, Niubo J, et al
    Total and Unbound Bictegravir Concentrations and Viral Suppression in CSF of HIV-infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56).
    J Infect Dis. 2019 Nov 30. pii: 5648079. doi: 10.1093.
    >> Share

  180. MARTIN GE, Pace M, Shearer FM, Zilber E, et al
    Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion.
    J Infect Dis. 2019 Nov 28. pii: 5644624. doi: 10.1093.
    >> Share

  181. KURITZKES DR
    New perspectives on the virologic consequences of M184V or I in HIV-1 Reverse Transcriptase.
    J Infect Dis. 2019 Nov 27. pii: 5644530. doi: 10.1093.
    >> Share

  182. GREGSON J, Rhee SY, Datir R, Pillay D, et al
    HIV-1 viral load is elevated in individuals with reverse transcriptase mutation M184V/I during virological failure of first line antiretroviral therapy and is associated with compensatory mutation L74I.
    J Infect Dis. 2019 Nov 27. pii: 5644529. doi: 10.1093.
    >> Share

  183. FLYS T, Nissley DV, Claasen CW, Jones D, et al
    Erratum to: Sensitive Drug-Resistance Assays Reveal Long-Term Persistence of HIV-1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single-Dose NVP: HIVNET 012.
    J Infect Dis. 2019 Nov 27. pii: 5644562. doi: 10.1093.
    >> Share

  184. TENG MN, Mejias A, Ramilo O, Peeples ME, et al
    Live Attenuated Vaccine with a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
    J Infect Dis. 2019 Nov 23. pii: 5638037. doi: 10.1093.
    >> Share

  185. JONGEN VW, Richel O, Marra E, Siegenbeek van Heukelom ML, et al
    Anal squamous intraepithelial lesions (aSIL) in HIV-positive MSM: incidence and risk factors of aSIL, and of progression and clearance of low-grade aSIL.
    J Infect Dis. 2019 Nov 22. pii: 5637764. doi: 10.1093.
    >> Share

  186. ALBERTS CJ, Heard I, Canestri A, Marchand L, et al
    Incidence and clearance of anal HPV-16 and HPV-18 infection, and their determinants, among HIV-infected men who have sex with men in France.
    J Infect Dis. 2019 Nov 22. pii: 5637552. doi: 10.1093.
    >> Share

  187. UGARTE A, Romero Y, Tricas A, Casado C, et al
    Unintended HIV-1 Infection During Analytical Therapy Interruption.
    J Infect Dis. 2019 Nov 19. pii: 5631859. doi: 10.1093.
    >> Share

  188. BALAGOPAL A, Hwang HS, Grudda T, Quinn J, et al
    Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Co-infection.
    J Infect Dis. 2019 Nov 19. pii: 5628941. doi: 10.1093.
    >> Share

  189. PEETLUK LS, Rebeiro PF, Cordeiro-Santos M, Kritski A, et al
    Lack of weight gain during the first two months of treatment and HIV independently predict unsuccessful treatment outcomes in tuberculosis.
    J Infect Dis. 2019 Nov 14. pii: 5625394. doi: 10.1093.
    >> Share

  190. GUDZA-MUGABE M, Havyarimana E, Jaumdally S, Garson KL, et al
    HIV infection is associated with preterm delivery independent of vaginal microbiota in pregnant African women.
    J Infect Dis. 2019 Nov 13. pii: 5624965. doi: 10.1093.
    >> Share

  191. SMITH C, Moraka NO, Ibrahim M, Moyo S, et al
    HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.
    J Infect Dis. 2019 Nov 10. pii: 5618838. doi: 10.1093.
    >> Share

  192. KOVACS AAZ, Kono N, Wang CH, Wang D, et al
    Association of HLA Genotype With T-Cell Activation in Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus-Coinfected Women.
    J Infect Dis. 2019 Nov 10. pii: 5618844. doi: 10.1093.
    >> Share

  193. TYMEJCZYK O, Brazier E, Wools-Kaloustian K, Davies MA, et al
    Impact of universal antiretroviral treatment eligibility on rapid treatment initiation among young adolescents with HIV in sub-Saharan Africa.
    J Infect Dis. 2019 Nov 4. pii: 5612125. doi: 10.1093.
    >> Share

  194. ZANONI BC, Haberer JE
    The meaning of "rapid" antiretroviral therapy initiation for adolescents with HIV in sub-Saharan Africa.
    J Infect Dis. 2019 Nov 4. pii: 5612131. doi: 10.1093.
    >> Share

  195. CUNNINGHAM CK, McFarland EJ, Morrison RL, Capparelli EV, et al
    Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.
    J Infect Dis. 2019 Nov 4. pii: 5611832. doi: 10.1093.
    >> Share

  196. GAEBLER C, Caskey M
    Broadly neutralizing anti-HIV antibodies in infants: promising new tools for prevention of mother-to-child transmission?
    J Infect Dis. 2019 Nov 4. pii: 5611834. doi: 10.1093.
    >> Share

  197. PRATOR CA, Thanh C, Kumar S, Pan T, et al
    Circulating CD30+ CD4+ T Cells Increase Prior to HIV Rebound Following Analytical Antiretroviral Treatment Interruption.
    J Infect Dis. 2019 Nov 2. pii: 5611164. doi: 10.1093.
    >> Share

  198. HUIJBEN S, Macete E, Mombo-Ngoma G, Ramharter M, et al
    Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
    J Infect Dis. 2019 Nov 2. pii: 5611162. doi: 10.1093.
    >> Share

    October 2019
  199. STEIN CM, Mayanja-Kizza H, Hawn TR, Boom WH, et al
    Importance of study design and phenotype definition in ongoing studies of resistance to latent M. tuberculosis infection.
    J Infect Dis. 2019 Oct 30. pii: 5609437. doi: 10.1093.
    >> Share

  200. COELHO-DOS-REIS JGA, Funakoshi R, Huang J, Pereira FV, et al
    Functional Human CD141+ Dendritic Cells in Human Immune System Mice.
    J Infect Dis. 2019 Oct 23. pii: 5606696. doi: 10.1093.
    >> Share

  201. KYOSIIMIRE-LUGEMWA J, Anywaine Z, Abaasa A, Levin J, et al
    Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy.
    J Infect Dis. 2019 Oct 23. pii: 5623996. doi: 10.1093.
    >> Share

  202. BOURKE CD, Prendergast AJ
    The Anti-inflammatory Effects of Cotrimoxazole Prophylaxis for People Living With Human Immunodeficiency Virus in Sub-Saharan Africa.
    J Infect Dis. 2019 Oct 23. pii: 5623995. doi: 10.1093.
    >> Share

  203. CHIHOTA BV, Wandeler G, Chilengi R, Mulenga L, et al
    High Rates of Hepatitis B Virus (HBV) Functional Cure Among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia.
    J Infect Dis. 2019 Oct 15. pii: 5581876. doi: 10.1093.
    >> Share

  204. KILAPANDAL VENKATRAMAN SM, Sivanandham R, Pandrea I, Apetrei C, et al
    BCG Vaccination and Mother-to-Infant Transmission of HIV.
    J Infect Dis. 2019 Oct 12. pii: 5586559. doi: 10.1093.
    >> Share

  205. WOOD MP, Wood LF, Templeton M, Fisher B, et al
    Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.
    J Infect Dis. 2019 Oct 12. pii: 5586557. doi: 10.1093.
    >> Share

  206. DRAIN PK, Gardiner J, Hannah H, Broger T, et al
    Guidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose Tuberculosis.
    J Infect Dis. 2019;220.
    >> Share

  207. SCHUMACHER SG, Wells WA, Nicol MP, Steingart KR, et al
    Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.
    J Infect Dis. 2019;220.
    >> Share

  208. GARDNER J, Laniewski P, Knight A, Haddad LB, et al
    IL-36gamma is elevated in cervicovaginal epithelial cells in women with bacterial vaginosis and in vitro after infection with microbes associated with bacterial vaginosis.
    J Infect Dis. 2019 Oct 5. pii: 5581767. doi: 10.1093.
    >> Share

  209. ELLSWORTH GB, Wilkin TJ
    Another Call for Widespread Human Papillomavirus Vaccination.
    J Infect Dis. 2019 Oct 5. pii: 5581839. doi: 10.1093.
    >> Share

  210. REDD AD, Doria-Rose NA, Weiner JA, Nason M, et al
    Longitudinal antibody responses in people who inject drugs infected with similar HIV strains.
    J Infect Dis. 2019 Oct 4. pii: 5580759. doi: 10.1093.
    >> Share

    September 2019
  211. CHEN P, Chen H, Moussa M, Cheng J, et al
    rhIL-15 and anti-PD-L1 combination therapy expands a CXCR3+PD1-/low CD8 T cell subset in SIV-infected rhesus macaques.
    J Infect Dis. 2019 Sep 28. pii: 5575818. doi: 10.1093.
    >> Share

  212. HANAJIRI R, Sani GM, Saunders D, Hanley PJ, et al
    Generation of Norovirus-Specific T-Cells from Human Donors with Extensive Cross-Reactivity to Variant Sequences: Implications for Immunotherapy.
    J Infect Dis. 2019 Sep 28. pii: 5575343. doi: 10.1093.
    >> Share

  213. YANG HI, Yeh ML, Wong GL, Peng CY, et al
    REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy.
    J Infect Dis. 2019 Sep 24. pii: 5573337. doi: 10.1093.
    >> Share

  214. FLYGEL TT, Sovershaeva E, Classen-Weitz S, Hjerde E, et al
    Composition of gut microbiota of children and adolescents with perinatal HIV infection taking antiretroviral therapy in Zimbabwe.
    J Infect Dis. 2019 Sep 24. pii: 5572969. doi: 10.1093.
    >> Share

  215. OJIKUTU BO, Mayer KH
    Hidden in Plain Sight: Identifying Women Living in the United States Who Could Benefit From HIV Preexposure Prophylaxis.
    J Infect Dis. 2019 Sep 24. pii: 5573044. doi: 10.1093.
    >> Share

  216. GUARALDI G, Milic J
    Why am I getting fat? Exploring immune-metabolic pathways to central fat accumulation in persons with HIV.
    J Infect Dis. 2019 Sep 20. pii: 5571883. doi: 10.1093.
    >> Share

  217. GELPI M, Ueland PM, Troseid M, Mocroft A, et al
    Abdominal adipose tissue is associated with alterations in tryptophan-kynurenine metabolism and markers of systemic inflammation in people with HIV.
    J Infect Dis. 2019 Sep 20. pii: 5571880. doi: 10.1093.
    >> Share

  218. PATEL P, Bush T, Conley L, Unger ER, et al
    Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.
    J Infect Dis. 2019 Sep 19. pii: 5571724. doi: 10.1093.
    >> Share

  219. EISINGER RW, Erbelding E, Fauci AS
    Refocusing Research on Sexually Transmitted Infections.
    J Infect Dis. 2019 Sep 9. pii: 5564379. doi: 10.1093.
    >> Share

    August 2019
  220. JOHNSON T, Folayan MO
    Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate.
    J Infect Dis. 2019;220:1233-1234.
    >> Share

  221. FOLAYAN MO, Haire B, Noseda V
    Re: Pre-Exposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment Interruption.
    J Infect Dis. 2019;220:1231-1233.
    >> Share

  222. DEE L, Boone CA, Palm D, Campbell D, et al
    Secondary HIV Infection and Mitigation in Cure-Related HIV Trials During Analytical Treatment Interruptions.
    J Infect Dis. 2019;220:1230-1231.
    >> Share

  223. KOSLOSKI MP, Oberoi R, Wang S, Viani RM, et al
    Drug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered with Human Immunodeficiency Virus Antiretrovirals.
    J Infect Dis. 2019 Aug 29. pii: 5556482. doi: 10.1093.
    >> Share

  224. NAIMAN NE, Slyker J, Nduati R, Overbaugh JM, et al
    Maternal envelope gp41 ectodomain-specific antibodies are associated with increased mother-to-child transmission of HIV-1.
    J Infect Dis. 2019 Aug 29. pii: 5556469. doi: 10.1093.
    >> Share

  225. TRAN VG, Venkatasubramaniam A, Adhikari RP, Krishnan S, et al
    Efficacy of Active Immunization with Attenuated Alpha-Hemolysin and Panton-Valentine Leukocidin in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.
    J Infect Dis. 2019 Aug 26. pii: 5554593. doi: 10.1093.
    >> Share

  226. EMMANUEL B, El-Kamary SS, Magder LS, Stafford KA, et al
    Metabolic Changes in Chronic Hepatitis C Patients who Carry IFNL4-DeltaG and Achieve Sustained Virologic Response with Direct-Acting Antiviral Therapy.
    J Infect Dis. 2019 Aug 26. pii: 5554606. doi: 10.1093.
    >> Share

  227. GODINHO-SANTOS A, Foxall RB, Antao AV, Tavares B, et al
    Follicular helper T cells are major HIV-2 reservoirs and support productive infection.
    J Infect Dis. 2019 Aug 26. pii: 5554703. doi: 10.1093.
    >> Share

  228. ISNARD S, Ramendra R, Dupuy FP, Lin J, et al
    Plasma levels of C-type lectin REG3alpha and gut damage in people with HIV.
    J Infect Dis. 2019 Aug 23. pii: 5553837. doi: 10.1093.
    >> Share

  229. CHEN X, Chen H, Zhang Z, Fu Y, et al
    Elevated CD54 expression renders CD4+ T cells susceptible to NK cell-mediated killing.
    J Infect Dis. 2019 Aug 21. pii: 5552704. doi: 10.1093.
    >> Share

  230. GIL RM, Hardy WD
    Spectrum of Diversity in Today's Infectious Diseases Workforce: It's Much Broader and Brighter Than You Think.
    J Infect Dis. 2019;220.
    >> Share

  231. RIOU C, Jhilmeet N, Rangaka MX, Wilkinson RJ, et al
    Tuberculosis antigen-specific T cell responses during the first 6 months of antiretroviral treatment.
    J Infect Dis. 2019 Aug 17. pii: 5550849. doi: 10.1093.
    >> Share

  232. AKDAG D, Knudsen AD, Thudium RF, Kirkegaard-Klitbo DM, et al
    Increased risk of anemia, neutropenia and thrombocytopenia in people with HIV and well-controlled viral replication.
    J Infect Dis. 2019 Aug 15. pii: 5550247. doi: 10.1093.
    >> Share

  233. CHOI YH, Perez-Cuevas MB, Kodani M, Zhang X, et al
    Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.
    J Infect Dis. 2019 Aug 13. pii: 5549399. doi: 10.1093.
    >> Share

  234. MUZNY CA, Taylor CM, Swords WE, Tamhane A, et al
    An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis.
    J Infect Dis. 2019 Aug 1. pii: 5542783. doi: 10.1093.
    >> Share

    July 2019
  235. MASSUD I, Cong ME, Ruone S, Holder A, et al
    Efficacy of oral tenofovir alafenamide/emtricitabine combination or single agent tenofovir alafenamide against vaginal SHIV infection in macaques.
    J Infect Dis. 2019 Jul 31. pii: 5541628. doi: 10.1093.
    >> Share

  236. MARSTON M, Gregson S
    HIV, ART and fertility in sub-Saharan Africa: pieces still missing in the jigsaw puzzle.
    J Infect Dis. 2019 Jul 23. pii: 5532046. doi: 10.1093.
    >> Share

  237. JOHNSON LF, Mutemaringa T, Heekes A, Boulle A, et al
    The effect of HIV and antiretroviral treatment on pregnancy rates in the Western Cape province of South Africa.
    J Infect Dis. 2019 Jul 23. pii: 5532045. doi: 10.1093.
    >> Share

  238. NABATANZI R, Bayigga L, Cose S, Rowland Jones S, et al
    Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African Cohort.
    J Infect Dis. 2019 Jul 19. pii: 5536380. doi: 10.1093.
    >> Share

  239. RYOM L, Lundgren JD, Reiss P, Kirk O, et al
    Use of contemporary protease inhibitors and risk of incident chronic kidney disease in HIV-positive persons; the D:A:D Study.
    J Infect Dis. 2019 Jul 16. pii: 5532715. doi: 10.1093.
    >> Share

  240. MARTIN NK, Jansen K, An der Heiden M, Boesecke C, et al
    Can HCV be eliminated among HIV-positive men who have sex with men in Berlin? A modeling analysis.
    J Infect Dis. 2019 Jul 12. pii: 5532024. doi: 10.1093.
    >> Share

  241. BOPPANA S, Sterrett S, Files J, Qin K, et al
    HLA-I associated adaptation dampens the CD8 T-cell response in HIV Ad5-vectored vaccine recipients.
    J Infect Dis. 2019 Jul 12. pii: 5532017. doi: 10.1093.
    >> Share

  242. VERRALL AJ, Alisjahbana B, Apriani L, Novianty N, et al
    Early Clearance of Mycobacterium tuberculosis: The INFECT Case Contact Cohort Study in Indonesia.
    J Infect Dis. 2019 Jul 12. pii: 5531576. doi: 10.1093.
    >> Share

  243. BOGORODSKAYA M, Fitch KV, Burdo TH, Maehler P, et al
    Serum Lipocalin-2/NGAL in Relation to Biomarkers of Inflammation and Cardiac Stretch During Activation of the Renin-Angiotensin-Aldosterone System (RAAS) in HIV.
    J Infect Dis. 2019 Jul 11. pii: 5531600. doi: 10.1093.
    >> Share

  244. MACATANGAY BJC, Jackson EK, Abebe KZ, Comer D, et al
    A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Hiv-Associated Chronic Inflammation.
    J Infect Dis. 2019 Jul 6. pii: 5529471. doi: 10.1093.
    >> Share

  245. MUTSAERTS EAML, Nunes MC, Bhikha S, Ikulinda BT, et al
    Immunogenicity and safety of an early measles vaccination schedule at 6 and 12 months of age in HIV-unexposed and HIV-exposed uninfected South African children.
    J Infect Dis. 2019 Jul 6. pii: 5529477. doi: 10.1093.
    >> Share

  246. UTAY NS, Overton ET
    Immune activation and inflammation in people with HIV: Challenging targets.
    J Infect Dis. 2019 Jul 6. pii: 5529472. doi: 10.1093.
    >> Share

  247. EYAL N
    How to Address the Risk of HIV Transmission in Remission Studies With Treatment Interruption: The Low-Hanging Fruit Approach.
    J Infect Dis. 2019;220.
    >> Share

  248. MARGOLIS DM, Deeks SG
    How Unavoidable Are Analytical Treatment Interruptions in HIV Cure-Related Studies?
    J Infect Dis. 2019;220.
    >> Share

  249. EYAL N
    Removing One Barrier to Protecting Sex Partners in HIV Remission Studies With a Treatment Interruption.
    J Infect Dis. 2019;220.
    >> Share

  250. DAWSON L
    Human Immunodeficiency Virus Transmission Risk in Analytical Treatment Interruption Studies: Relational Factors and Moral Responsibility.
    J Infect Dis. 2019;220.
    >> Share

  251. EYAL N, Magalhaes M
    Is it ethical to isolate study participants to prevent HIV transmission during trials with an analytical treatment interruption?
    J Infect Dis. 2019;220.
    >> Share

  252. EYAL N, Deeks SG
    Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium.
    J Infect Dis. 2019;220.
    >> Share

    June 2019
  253. ROH ME, Tessema SK, Murphy M, Nhlabathi N, et al
    High genetic diversity of Plasmodium falciparum in the low transmission setting of the Kingdom of Eswatini.
    J Infect Dis. 2019 Jun 13. pii: 5514501. doi: 10.1093.
    >> Share

  254. EKENBERG C, Tang ME, Zucco AG, Murray DD, et al
    Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-naive participants from the START trial.
    J Infect Dis. 2019 Jun 13. pii: 5521002. doi: 10.1093.
    >> Share

  255. SIEDNER MJ, Bwana MB, Asiimwe S, Amanyire G, et al
    Timing of Antiretroviral Therapy and Systemic Inflammation in Sub-Saharan Africa: Results From the META Longitudinal Cohort Study.
    J Infect Dis. 2019 Jun 12. pii: 5514246. doi: 10.1093.
    >> Share

  256. MARKOWITZ M, Gettie A, St Bernard L, Andrews CD, et al
    Title: Once-weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques from Intrarectal SHIV109CP3 Challenge.
    J Infect Dis. 2019 Jun 7. pii: 5513016. doi: 10.1093.
    >> Share

  257. MUGWANYA KK, Baeten JM
    Next-Generation Pre-Exposure Prophylaxis: Choices for Effective HIV Prevention.
    J Infect Dis. 2019 Jun 7. pii: 5513001. doi: 10.1093.
    >> Share

  258. WANGDAHL A, Wyss K, Saduddin D, Bottai M, et al
    Severity of Plasmodium falciparum and non-falciparum malaria in travelers and migrants: a nationwide observational study over two decades in Sweden.
    J Infect Dis. 2019 Jun 6. pii: 5512705. doi: 10.1093.
    >> Share

    May 2019
  259. HOENIGL M, Little SJ
    Salvage Antiretroviral Therapy: Time for "DeNUKElearization"?
    J Infect Dis. 2019 May 28. pii: 5499363. doi: 10.1093.
    >> Share

  260. GANDHI RT, Tashima KT, Smeaton LM, Vu V, et al
    Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-week Results of AIDS Clinical Trials Group A5241 (OPTIONS).
    J Infect Dis. 2019 May 28. pii: 5499329. doi: 10.1093.
    >> Share

  261. SACCOCCIO FM, Jenks JA, Itell HL, Li SH, et al
    Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.
    J Infect Dis. 2019 May 20. pii: 5492326. doi: 10.1093.
    >> Share

  262. ZANNI MV, Awadalla M, Toribio M, Robinson J, et al
    Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus.
    J Infect Dis. 2019 May 17. pii: 5475917. doi: 10.1093.
    >> Share

  263. DAI L, Qiao J, Yin J, Goldstein A, et al
    KSHV and Staphylococcus aureus co-infection in oral cavities of HIV+ patients: a unique niche for oncogenic virus lytic reactivation.
    J Infect Dis. 2019 May 17. pii: 5491269. doi: 10.1093.
    >> Share

  264. KROEZE S, Wit FW, Rossouw TM, Steel HC, et al
    Plasma biomarkers of HIV-related systemic inflammation and immune activation in sub-Saharan Africa before and during suppressive antiretroviral therapy.
    J Infect Dis. 2019 May 14. pii: 5489039. doi: 10.1093.
    >> Share

  265. HOEL H, Ueland T, Knudsen A, Kjaer A, et al
    Soluble markers of IL-1 activation as predictors of first-time myocardial infarction in HIV-infected individuals.
    J Infect Dis. 2019 May 11. pii: 5488093. doi: 10.1093.
    >> Share

  266. CURRIER JS, Hsue P
    The Role of Inflammation in HIV-associated Atherosclerosis - One Size May Not Fit All.
    J Infect Dis. 2019 May 11. pii: 5488098. doi: 10.1093.
    >> Share

  267. FOURMAN LT, Saylor CF, Cheru L, Fitch K, et al
    Anti-Inflammatory Interleukin-10 is Inversely Related to Coronary Atherosclerosis in People with Hiv.
    J Infect Dis. 2019 May 11. pii: 5488095. doi: 10.1093.
    >> Share

  268. AMOAH S, Mishina M, Praphasiri P, Cao W, et al
    Standard dose intradermal influenza vaccine elicits similar cellular immune responses when compared to intramuscular vaccine in HIV-infected or uninfected men.
    J Infect Dis. 2019 May 2. pii: 5482500. doi: 10.1093.
    >> Share

  269. SUAREZ NM, Musonda KG, Escriva E, Njenga M, et al
    Multiple-Strain Infections of Human Cytomegalovirus with High Genomic Diversity are Common In Breast Milk from HIV-Positive Women in Zambia.
    J Infect Dis. 2019 May 2. pii: 5485308. doi: 10.1093.
    >> Share

    April 2019
  270. FRANCE AM, Oster AM
    The Promise and Complexities of Detecting and Monitoring HIV Transmission Clusters.
    J Infect Dis. 2019 Apr 27. pii: 5481004. doi: 10.1093.
    >> Share

  271. DENNIS AM, Hue S, Billock R, Levintow S, et al
    HIV-1 Phylodynamics to Detect and Characterize Active Transmission Clusters in North Carolina.
    J Infect Dis. 2019 Apr 27. pii: 5480993. doi: 10.1093.
    >> Share

  272. KELLER MJ, Huber A, Espinoza L, Serrano MG, et al
    Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome.
    J Infect Dis. 2019 Apr 27. pii: 5481045. doi: 10.1093.
    >> Share

  273. MOAYEDI Y, Walmsley SL
    Heart Failure With Preserved Ejection Fraction in Women Living With HIV: Another Inflammatory Comorbidity?
    J Infect Dis. 2019 Apr 22. pii: 5475920. doi: 10.1093.
    >> Share

  274. BLUMENTHAL MJ, Schutz C, Barr D, Locketz M, et al
    The contribution of KSHV to mortality in hospitalized HIV-infected patients being investigated for tuberculosis in South Africa.
    J Infect Dis. 2019 Apr 20. pii: 5475547. doi: 10.1093.
    >> Share

  275. BAUDE J, Bastien S, Gillet Y, Leblanc P, et al
    Necrotizing Soft Tissue Infections S.aureus - but not S.pyogenes- isolates display high rate of internalization and cytotoxicity toward human myoblasts.
    J Infect Dis. 2019 Apr 19. pii: 5475174. doi: 10.1093.
    >> Share

  276. VERRALL AJ, Schneider M, Alisjahbana B, Apriani L, et al
    Early clearance of Mycobacterium tuberculosis is associated with increased innate immune responses.
    J Infect Dis. 2019 Apr 8. pii: 5431213. doi: 10.1093.
    >> Share

  277. KENYON C, Buyze J, Spiteri G, Cole MJ, et al
    Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis.
    J Infect Dis. 2019 Apr 8. pii: 5430759. doi: 10.1093.
    >> Share

  278. SYKES W, van den Berg K, Jacobs G, Jauregui A, et al
    Discovery of "false Elite Controllers": HIV antibody-positive RNA-negative blood donors found to be on antiretroviral treatment.
    J Infect Dis. 2019 Apr 5. pii: 5428557. doi: 10.1093.
    >> Share

  279. ROBERTSON MM, Braunstein SL, Hoover DR, Li S, et al
    Timeliness of HIV Diagnosis and Antiretroviral Treatment Initiation in the Era of Universal Test and Treat.
    J Infect Dis. 2019 Apr 4. pii: 5427896. doi: 10.1093.
    >> Share

  280. MORROW M, Mawhinney S, Coyle RP, Coleman SS, et al
    Predictive value of tenofovir diphosphate in dried blood spots for future viremia in persons living with HIV.
    J Infect Dis. 2019 Apr 3. pii: 5426853. doi: 10.1093.
    >> Share

  281. SCHWETZ TA, Calder T, Rosenthal E, Kattakuzhy S, et al
    Opioids and Infectious Diseases: A Converging Public Health Crisis.
    J Infect Dis. 2019 Apr 3. pii: 5426470. doi: 10.1093.
    >> Share

  282. PRICE MA, Rida W, Kilembe W, Karita E, et al
    HIV-1 viral control varies by viral subtype in a large cohort of African adults with incident HIV-1 infection.
    J Infect Dis. 2019 Apr 2. pii: 5425476. doi: 10.1093.
    >> Share

    March 2019
  283. ABARA WE, Trujillo L, Broz D, Finlayson T, et al
    Age-related Differences in Past or Present HCV Infection among People Who Inject Drugs - National HIV Behavioral Surveillance, Eight U.S Cities, 2015.
    J Infect Dis. 2019 Mar 27. pii: 5420467. doi: 10.1093.
    >> Share

  284. GODFREY C, Bremer A, Alba D, Apovian C, et al
    Obesity and Fat Metabolism in HIV-infected Individuals: Immunopathogenic Mechanisms and Clinical Implications.
    J Infect Dis. 2019 Mar 20. pii: 5407906. doi: 10.1093.
    >> Share

  285. COSTANTINI S, Walensky RP
    The Costs of Drugs in Infectious Diseases: Branded, Generics, and Why We Should Care.
    J Infect Dis. 2019 Mar 19. pii: 5385524. doi: 10.1093.
    >> Share

  286. LOISEAU C, Requena M, Nayrac M, Mavigner M, et al
    Increase of CXCR3+ T cells impairs Th17 cells recruitment in the small intestine mucosa through IFN-gamma and IL-18 during treated HIV-1 infection.
    J Infect Dis. 2019 Mar 18. pii: 5382280. doi: 10.1093.
    >> Share

  287. KHOSROPOUR CM, Soge OO, Suchland R, Leipertz G, et al
    Recurrent/intermittent vaginal and rectal chlamydial infection following treatment: a prospective cohort study among female STD clinic patients.
    J Infect Dis. 2019 Mar 12. pii: 5381072. doi: 10.1093.
    >> Share

  288. LELIEVRE JD
    Preexposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment Interruption.
    J Infect Dis. 2019 Mar 12. pii: 5376539. doi: 10.1093.
    >> Share

  289. AEPFELBACHER JA, Balmaceda J, Purdy J, Mattingly A, et al
    Increased Prevalence of Hepatic Steatosis in Young Adults with Life-long HIV.
    J Infect Dis. 2019 Mar 10. pii: 5372968. doi: 10.1093.
    >> Share

  290. HUITING ED, Gittens K, Justement JS, Shi V, et al
    Impact of treatment interruption on HIV reservoirs and lymphocyte subsets in individuals who had initiated antiretroviral therapy during the early phase of infection.
    J Infect Dis. 2019 Mar 6. pii: 5370431. doi: 10.1093.
    >> Share

  291. KUSEJKO K, Bachmann N, Chaudron SE, Nguyen H, et al
    A systematic phylogenetic approach to study the interaction of HIV-1 with coinfections, non-communicable and opportunistic diseases.
    J Infect Dis. 2019 Mar 4. pii: 5369724. doi: 10.1093.
    >> Share

  292. CARLISLE LA, Turk T, Kusejko K, Metzner KJ, et al
    Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection.
    J Infect Dis. 2019 Mar 4. pii: 5369731. doi: 10.1093.
    >> Share

    February 2019
  293. VASYLYEVA TI, du Plessis L, Pineda-Pena AC, Kuhnert D, et al
    Tracing the Impact of Public Health Interventions on HIV-1 Transmission in Portugal Using Molecular Epidemiology.
    J Infect Dis. 2019 Feb 26. pii: 5364937. doi: 10.1093.
    >> Share

  294. LELIEVRE JD, Hocqueloux L
    Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate.
    J Infect Dis. 2019 Feb 16. pii: 5344456. doi: 10.1093.
    >> Share

  295. SALAZAR-VIZCAYA L, Kouyos RD, Metzner KJ, Caraballo Cortes K, et al
    Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up era.
    J Infect Dis. 2019 Feb 13. pii: 5318573. doi: 10.1093.
    >> Share

  296. MARRAZZO JM, Rabe L, Kelly C, Richardson B, et al
    Tenofovir gel for prevention of herpes simplex virus type-2 acquisition: findings from the VOICE Trial.
    J Infect Dis. 2019 Feb 11. pii: 5315462. doi: 10.1093.
    >> Share

  297. LEUNG J, Peacock A, Colledge S, Grebely J, et al
    A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators?
    J Infect Dis. 2019 Feb 6. pii: 5307802. doi: 10.1093.
    >> Share

  298. SORTINO O, Huppler Hullsiek K, Richards E, Rupert A, et al
    The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among People Living with HIV Receiving Antiretroviral Therapy.
    J Infect Dis. 2019 Feb 4. pii: 5306488. doi: 10.1093.
    >> Share

  299. KARLSSON I, Tingstedt JL, Sahin GO, Hansen M, et al
    Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected Individuals.
    J Infect Dis. 2019 Feb 2. pii: 5305980. doi: 10.1093.
    >> Share

    January 2019
  300. MULLICK C, Murray J
    Correlations between HIV infection and rectal gonorrhea incidence in men who have sex with men: Implications for future HIV pre-exposure prophylaxis trials.
    J Infect Dis. 2019 Jan 31. pii: 5304966. doi: 10.1093.
    >> Share

  301. COHEN MS, Donnell D
    Novel approaches for development of HIV pre-exposure prophylaxis (PrEP) agents.
    J Infect Dis. 2019 Jan 31. pii: 5304967. doi: 10.1093.
    >> Share

  302. FREEMAN ML, Panigrahi S, Chen B, Juchnowski S, et al
    CD8+ T Cell-Derived Tumor Necrosis Factor Can Induce Tissue Factor Expression on Monocytes.
    J Infect Dis. 2019 Jan 29. pii: 5304106. doi: 10.1093.
    >> Share

  303. GISSLEN M, Hunt PW
    Antiretroviral treatment of acute HIV infection normalizes CSF markers of CNS inflammation. A consequence of reduced CNS reservoir?
    J Infect Dis. 2019 Jan 21. pii: 5298346. doi: 10.1093.
    >> Share

  304. HELLMUTH J, Slike BM, Sacdalan C, Best J, et al
    Very early ART initiation during acute HIV infection is associated with normalization of cerebrospinal fluid but not plasma markers of immune activation.
    J Infect Dis. 2019 Jan 21. pii: 5298345. doi: 10.1093.
    >> Share

  305. MATHUR R, Hui Q, Huang Y, Gwinn M, et al
    DNA Methylation Markers of Type 2 Diabetes among HIV-Positive and -Negative Male Veterans.
    J Infect Dis. 2019 Jan 11. pii: 5288496. doi: 10.1093.
    >> Share

  306. KELLY C, Mwandumba HC, Heyderman RS, Jambo K, et al
    HIV-related arterial stiffness in Malawian adults is associated with proportion of PD-1 expressing CD8 T-cells and reverses with anti-retroviral therapy.
    J Infect Dis. 2019 Jan 9. pii: 5283190. doi: 10.1093.
    >> Share

  307. MUENCHHOFF M, Adland E, Roider J, Kloverpris H, et al
    Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children.
    J Infect Dis. 2019 Jan 8. pii: 5280900. doi: 10.1093.
    >> Share

  308. SINGH A, Prasad S
    The Immune Checkpoint Protein Programmed Death 1 During HIV Infection in Children: Clinical Relevance and Beyond.
    J Infect Dis. 2019 Jan 8. pii: 5280901. doi: 10.1093.
    >> Share

  309. SPEARMAN P, Tomaras GD, Montefiori DC, Huang Y, et al
    Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest.
    J Infect Dis. 2019 Jan 7. pii: 5280104. doi: 10.1093.
    >> Share

  310. RAGHWANI J, Wu CH, Ho CKY, De Jong M, et al
    High resolution evolutionary analysis of within-host hepatitis C virus infection.
    J Infect Dis. 2019 Jan 2. pii: 5269822. doi: 10.1093.
    >> Share

    December 2018
  311. DUPNIK KM, Lee MH, Mishra P, Reust MJ, et al
    Altered cervical mucosal gene expression and lower IL-15 levels in women with S. haematobium but not S. mansoni infection.
    J Infect Dis. 2018 Dec 25. pii: 5260846. doi: 10.1093.
    >> Share

  312. ROSE R, Hall M, Redd AD, Lamers S, et al
    Phylogenetic methods inconsistently predict direction of HIV transmission among heterosexual pairs in the HPTN052 cohort.
    J Infect Dis. 2018 Dec 24. pii: 5259209. doi: 10.1093.
    >> Share

  313. GUNTHARD HF, Kouyos R
    Can directionality of HIV transmission be predicted by next generation sequencing data?
    J Infect Dis. 2018 Dec 24. pii: 5259182. doi: 10.1093.
    >> Share

  314. HELLFERSCEE O, Treurnicht FK, Walaza S, du Plessis M, et al
    The fraction of rhinovirus detections attributable to mild and severe respiratory illness in a high HIV-prevalence setting, South Africa, 2013-2015.
    J Infect Dis. 2018 Dec 22. pii: 5257995. doi: 10.1093.
    >> Share

  315. NASI M, Pecorini S, De Biasi S, Bianchini E, et al
    Altered expression of PYCARD, IL-1beta, IL-18 and NAIP in successfully treated HIV+ patients with low CD4/CD8 ratio.
    J Infect Dis. 2018 Dec 21. pii: 5257417. doi: 10.1093.
    >> Share

  316. FRANK DJ, Horne DJ, Dutta NK, Shaku MT, et al
    Remembering the Host in Tuberculosis Drug Development.
    J Infect Dis. 2018 Dec 21. pii: 5257354. doi: 10.1093.
    >> Share

  317. COOLEY SA, Strain JF, Beaumont H, Boerwinkle AH, et al
    Tau Positron Emission Tomography Binding Is Not Elevated in HIV-Infected Individuals.
    J Infect Dis. 2018 Dec 17. pii: 5250730. doi: 10.1093.
    >> Share

  318. ROSENBERG ES, Doyle K, Munoz-Jordan JL, Klein L, et al
    Prevalence and incidence of Zika virus infection among household contacts of patients with Zika virus disease, Puerto Rico, 2016-2017.
    J Infect Dis. 2018 Dec 13. pii: 5244593. doi: 10.1093.
    >> Share

  319. COHEN C, Tshangela A, Valley-Omar Z, Iyengar P, et al
    Household transmission of seasonal influenza from HIV-infected and -uninfected individuals in South Africa, 2013-2014.
    J Infect Dis. 2018 Dec 12. pii: 5240968. doi: 10.1093.
    >> Share

  320. MORI M, Leitman E, Walker B, Ndung'u T, et al
    Impact of HLA allele-KIR pairs on HIV clinical outcome in South Africa.
    J Infect Dis. 2018 Dec 6. pii: 5231981. doi: 10.1093.
    >> Share

    November 2018
  321. MANN LM, Llata E, Flagg EW, Hong J, et al
    Trends of Anogenital Warts Among Sexually Transmitted Disease Clinic Patients - Sexually Transmitted Disease Surveillance Network, United States, 2010-2016.
    J Infect Dis. 2018 Nov 29. pii: 5219029. doi: 10.1093.
    >> Share

  322. SUN J, Longchamps RJ, Piggott DA, Castellani CA, et al
    The association between HIV infection and mitochondrial DNA copy number in peripheral blood: a population-based, prospective cohort study.
    J Infect Dis. 2018 Nov 24. pii: 5204254. doi: 10.1093.
    >> Share

  323. PRICE JC, McKinney JE, Crouch PC, Dillon SM, et al
    Sexually Acquired Hepatitis C Infection in HIV-uninfected Men Who Have Sex with Men Using Pre-exposure Prophylaxis Against HIV.
    J Infect Dis. 2018 Nov 20. pii: 5193510. doi: 10.1093.
    >> Share

  324. LIDENGE SJ, Tso FY, Ngalamika O, Ngowi JR, et al
    Similar Immunological Profiles Between African Endemic and HIV1-associated Epidemic Kaposi's Sarcoma Patients Reveal the Primary Role of KSHV in KS Pathogenesis.
    J Infect Dis. 2018 Nov 19. pii: 5191126. doi: 10.1093.
    >> Share

  325. TOMASICCHIO M, Davids M, Pooran A, Theron G, et al
    The injectable contraceptive medroxyprogesterone acetate attenuates Mycobacterium tuberculosis-specific host immunity through the glucocorticoid receptor.
    J Infect Dis. 2018 Nov 19. pii: 5191220. doi: 10.1093.
    >> Share

  326. VERBOEKET SO, Wit FW, Kirk GD, Drummond MB, et al
    Reduced Forced Vital Capacity among HIV-infected middle-aged individuals.
    J Infect Dis. 2018 Nov 12. pii: 5173872. doi: 10.1093.
    >> Share

    October 2018
  327. BOILY-LAROUCHE G, Lajoie J, Dufault B, Omollo K, et al
    Characterization of the Genital Mucosa Immune Profile to Distinguish Phases of the Menstrual Cycle: Implications for HIV Susceptibility.
    J Infect Dis. 2018 Oct 31. pii: 5151356. doi: 10.1093.
    >> Share

  328. SCULLY EP, Gandhi M, Johnston R, Hoh R, et al
    Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation.
    J Infect Dis. 2018 Oct 29. pii: 5146028. doi: 10.1093.
    >> Share

  329. LAROUCHE A, Milton McSween KA, Calderon V, Fauteux-Daniel S, et al
    Quasispecies Diversity Is a Major Risk Factor for Vertical Hepatitis C Virus Transmission.
    J Infect Dis. 2018 Oct 25. pii: 5144832. doi: 10.1093.
    >> Share

  330. TUGUME L, Rhein J, Hullsiek KH, Mpoza E, et al
    HIV-associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 counts.
    J Infect Dis. 2018 Oct 16. pii: 5132970. doi: 10.1093.
    >> Share

  331. RODRIGUEZ-GALLEGO E, Tarancon-Diez L, Garcia F, Del Romero J, et al
    Proteomic Profile Associated with Loss of Spontaneous HIV-1 Elite Control.
    J Infect Dis. 2018 Oct 12. pii: 5127217. doi: 10.1093.
    >> Share

  332. SUTHAR AB, Coggin W, Raizes E
    Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS.
    J Infect Dis. 2018 Oct 11. pii: 5126519. doi: 10.1093.
    >> Share

  333. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Reply to Suthar et al.
    J Infect Dis. 2018 Oct 11. pii: 5126520. doi: 10.1093.
    >> Share

  334. XIA Q, Coeytaux K, Braunstein SL, Torian LV, et al
    Proposing a New Indicator for the National Human Immunodeficiency Virus/AIDS Strategy: Percentage of Newly Diagnosed Persons Achieving Viral Suppression Within 3 Months of Diagnosis.
    J Infect Dis. 2018 Oct 10. pii: 5116324. doi: 10.1093.
    >> Share

  335. DOMBROWSKI JC, Baeten JM
    It's Time to Make the Time to Viral Suppression After HIV Diagnosis a Metric of HIV Care Success.
    J Infect Dis. 2018 Oct 10. pii: 5116321. doi: 10.1093.
    >> Share

  336. SZANIAWSKI MA, Spivak AM, Bosque A, Planelles V, et al
    Sex influences SAMHD1 activity and susceptibility to HIV-1 in primary human macrophages.
    J Infect Dis. 2018 Oct 8. pii: 5123692. doi: 10.1093.
    >> Share

  337. RICHARDS V
    Should we consider marijuana use in relation to physical activity and cognitive impairment in persons with HIV infection?
    J Infect Dis. 2018 Oct 5. pii: 5115716. doi: 10.1093.
    >> Share

  338. JAIMES-BERNAL C, Rallon N, Benito JM, Mohamed-Balghata MO, et al
    Knock-out IFNL4 gene variant is associated with protection from sexually transmitted HIV-1 infection.
    J Infect Dis. 2018 Oct 5. pii: 5115710. doi: 10.1093.
    >> Share

    September 2018
  339. MARRA E, Lin C, Clifford GM
    Type-specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: a systematic literature review and meta-analysis.
    J Infect Dis. 2018 Sep 20. pii: 5103515. doi: 10.1093.
    >> Share

  340. GUPTA SK, Liu Z, Sims EC, Repass MJ, et al
    Endothelial Colony Forming Cell Function Is Reduced in HIV.
    J Infect Dis. 2018 Sep 18. pii: 5099934. doi: 10.1093.
    >> Share

  341. KEHRMANN J, Menzel J, Saeedghalati M, Obeid R, et al
    Gut microbiota in HIV-infected individuals linked to coronary heart disease.
    J Infect Dis. 2018 Sep 7. pii: 5092661. doi: 10.1093.
    >> Share

    August 2018
  342. SCHWETZ TA, Fauci AS
    The Extended Impact of Human Immunodeficiency Virus/AIDS Research.
    J Infect Dis. 2018 Aug 28. pii: 5063659. doi: 10.1093.
    >> Share

  343. LEDDY AM, Roque A, Sheira LA, Frongillo EA, et al
    Food insecurity is associated with inflammation among women living with HIV.
    J Infect Dis. 2018 Aug 27. pii: 5080937. doi: 10.1093.
    >> Share

  344. LETIZIA A, Eller MA, Polyak C, Eller LA, et al
    Biomarkers of Inflammation Correlate with Clinical Scoring Indices in HIV-Infected Kenyans.
    J Infect Dis. 2018 Aug 27. pii: 5082069. doi: 10.1093.
    >> Share

  345. RICHTERMAN A, Sainvilien DR, Eberly L, Ivers LC, et al
    Individual and Household Risk Factors for Symptomatic Cholera Infection: A Systematic Review and Meta-analysis.
    J Infect Dis. 2018 Aug 18. pii: 5076163. doi: 10.1093.
    >> Share

  346. CHOW FC, Makanjuola A, Wu K, Berzins B, et al
    Physical activity is associated with lower odds of cognitive impairment in women but not men living with HIV infection.
    J Infect Dis. 2018 Aug 18. pii: 5075993. doi: 10.1093.
    >> Share

  347. PUDNEY J, Wangu Z, Panther L, Fugelso D, et al
    Condylomata acuminata (anogenital warts) contain accumulations of HIV-1 target cells that may provide portals for HIV transmission.
    J Infect Dis. 2018 Aug 18. pii: 5076076. doi: 10.1093.
    >> Share

  348. SINGH U, Levy J, Armstrong W, Bedimo R, et al
    Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist Workforce.
    J Infect Dis. 2018;218.
    >> Share

  349. MERIGAN TC
    Role of Physician-Scientists in the Control of Human Immunodeficiency Virus.
    J Infect Dis. 2018;218.
    >> Share

  350. FITZGERALD FC, Lhomme E, Harris K, Kenny J, et al
    Microbial translocation does not drive immune activation in Ugandan children with HIV.
    J Infect Dis. 2018 Aug 11. pii: 5070381. doi: 10.1093.
    >> Share

  351. THOENS C, Heinold A, Lindemann M, Horn PA, et al
    A single nucleotide polymorphism upstream of the HLA-C locus is associated with an anti-HCV seronegative state in a high-risk exposed cohort.
    J Infect Dis. 2018 Aug 9. pii: 5068404. doi: 10.1093.
    >> Share

  352. NAMAZI G, Fajnzylber JM, Aga E, Bosch R, et al
    The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies.
    J Infect Dis. 2018 Aug 6. pii: 5067282. doi: 10.1093.
    >> Share

  353. DARCIS G, Berkhout B
    HIV resistance to dolutegravir: are we looking at the wrong place?
    J Infect Dis. 2018 Aug 2. pii: 5063806. doi: 10.1093.
    >> Share

    July 2018
  354. DHUMMAKUPT A, Siems LV, Singh D, Chen YH, et al
    The Latent HIV Reservoir Resides Primarily in CD32- CD4+ T Cells in Perinatally, HIV-Infected Adolescents with Long-Term Virologic Suppression.
    J Infect Dis. 2018 Jul 21. pii: 5057007. doi: 10.1093.
    >> Share

  355. LIU Y, Sigel K, Gaisa MM
    HPV Genotypes Predict Progression of Anal Low-grade Squamous Intraepithelial Lesions.
    J Infect Dis. 2018 Jul 21. pii: 5057008. doi: 10.1093.
    >> Share

  356. SIEDNER MJ, Triant V
    Undetectable = Untransmittable and Your Health: The personal benefits of early and continuous therapy for HIV infection.
    J Infect Dis. 2018 Jul 19. pii: 5055762. doi: 10.1093.
    >> Share

  357. ZHANG WW, Cheung PK, Oliviera N, Robbins MA, et al
    Accumulation of multiple mutations in vivo confers cross-resistance to new and existing integrase inhibitors.
    J Infect Dis. 2018 Jul 16. pii: 5054084. doi: 10.1093.
    >> Share

  358. DENNIS AM, Zhou S, Sellers CJ, Learner E, et al
    Using Primer-ID Deep Sequencing to Detect Recent HIV-1 Infection.
    J Infect Dis. 2018 Jul 16. pii: 5054087. doi: 10.1093.
    >> Share

  359. YOON HA, Nakouzi A, Chang CC, Kuniholm MH, et al
    Association between plasma antibody responses and risk for Cryptococcus-associated immune reconstitution inflammatory syndrome.
    J Infect Dis. 2018 Jul 16. pii: 5054280. doi: 10.1093.
    >> Share

  360. WERTHEIM JO, Murrell B, Mehta SR, Forgione LA, et al
    Growth of HIV-1 Molecular Transmission Clusters in New York City.
    J Infect Dis. 2018 Jul 14. pii: 5053881. doi: 10.1093.
    >> Share

  361. LOPEZ-CORTES LF, Trujillo-Rodriguez M, Baez-Palomo A, Benmarzouk-Hidalgo OJ, et al
    Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
    J Infect Dis. 2018 Jul 6. pii: 5050122. doi: 10.1093.
    >> Share

  362. JOSE S, Hamzah L, Jones R, Williams D, et al
    Chronic Kidney Disease Risk in African and Caribbean Populations with HIV.
    J Infect Dis. 2018 Jul 6. pii: 5049787. doi: 10.1093.
    >> Share

  363. NING T, Nie J, Huang W, Li C, et al
    Antigenic Drift of H7N9 Viral Hemagglutinin.
    J Infect Dis. 2018 Jul 5. pii: 5049177. doi: 10.1093.
    >> Share

  364. STELLA-ASCARIZ N, Montejano R, Rodriguez-Centeno J, Alejos B, et al
    Blood Telomere Length Changes after Ritonavir-boosted Darunavir Combined with Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected with HIV-1.
    J Infect Dis. 2018 Jul 3. pii: 5048609. doi: 10.1093.
    >> Share

  365. GEBREMICAEL G, Kassa D, Quinten E, Alemayehu Y, et al
    Host gene expression kinetics during treatment of tuberculosis in HIV-coinfected individuals is independent of HAART therapy.
    J Infect Dis. 2018 Jul 2. pii: 5047436. doi: 10.1093.
    >> Share

  366. FULCHER JA, Hussain SK, Cook R, Li F, et al
    Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1 Infection.
    J Infect Dis. 2018 Jul 2. pii: 5047923. doi: 10.1093.
    >> Share

    June 2018
  367. RAMJEE G, Dassaye R, Reddy T, Wand H, et al
    Targeted pregnancy and HIV prevention risk-reduction counselling for young women: lessons learned from biomedical prevention trials.
    J Infect Dis. 2018 Jun 26. pii: 5045583. doi: 10.1093.
    >> Share

  368. SHIPLEY MM, Renner DW, Ott M, Bloom DC, et al
    Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time.
    J Infect Dis. 2018 Jun 18. pii: 5039658. doi: 10.1093.
    >> Share

  369. MESHER D, Panwar K, Thomas SL, Edmundson C, et al
    The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016.
    J Infect Dis. 2018 Jun 18. pii: 5025126. doi: 10.1093.
    >> Share

  370. COTE HCF, Hsieh AYY
    Leukocyte telomere length in HIV infection: A marker of persistent immune aging or transient immune reconstitution?
    J Infect Dis. 2018 Jun 15. pii: 5038297. doi: 10.1093.
    >> Share

  371. MONTEJANO R, Stella-Ascariz N, Monge S, Bernardino JI, et al
    Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV-1 infected Adults.
    J Infect Dis. 2018 Jun 15. pii: 5038298. doi: 10.1093.
    >> Share

  372. SHAN Z, Clish CB, Hua S, Scott JM, et al
    Gut Microbial-related Choline Metabolite Trimethylamine-N-oxide is Associated with Progression of Carotid Artery Atherosclerosis in HIV Infection.
    J Infect Dis. 2018 Jun 15. pii: 5038303. doi: 10.1093.
    >> Share

  373. RAO M, Onkar S, Peachman KK, White Y, et al
    Liposome-Encapsulated HIV-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans.
    J Infect Dis. 2018 Jun 9. pii: 5035293. doi: 10.1093.
    >> Share

  374. ALI A, Ng HL, Blankson JN, Burton DR, et al
    Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1.
    J Infect Dis. 2018 Jun 7. pii: 5033983. doi: 10.1093.
    >> Share

  375. LIDOFSKY A, Holmes JA, Feeney ER, Kruger AJ, et al
    Macrophage Activation Marker Soluble CD163 is a Dynamic Marker of Liver Fibrogenesis in HIV/HCV Coinfection.
    J Infect Dis. 2018 Jun 4. pii: 5032604. doi: 10.1093.
    >> Share

  376. D'ANTONI ML, Byron MM, Chan P, Sailasuta N, et al
    Normalization of Soluble CD163 after Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities.
    J Infect Dis. 2018 Jun 2. pii: 5032504. doi: 10.1093.
    >> Share

    May 2018
  377. JOHNSON EL, Boggavarapu S, Johnson ES, Lal A, et al
    HCMV enhances placental susceptibility and replication of HIV-1 which may facilitate in utero HIV-1 transmission.
    J Infect Dis. 2018 May 31. pii: 5026120. doi: 10.1093.
    >> Share

  378. KELLY H, Faust H, Chikandiwa A, Ngou J, et al
    Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection.
    J Infect Dis. 2018 May 30. pii: 5025554. doi: 10.1093.
    >> Share

  379. PERCIANI CT, Sekhon M, Hundal S, Farah B, et al
    Live-attenuated Zoster Vaccine Boosts VZV-specific Humoral Responses Systemically and at the Cervico-vaginal Mucosa of Kenyan VZV-seropositive Women.
    J Infect Dis. 2018 May 25. pii: 5003463. doi: 10.1093.
    >> Share

  380. ANDERSEN MN, Honge BL, Jespersen S, Medina C, et al
    Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in HIV-infection.
    J Infect Dis. 2018 May 25. pii: 5003428. doi: 10.1093.
    >> Share

  381. VON MOLLENDORF C, Hellferscee O, Valley-Omar Z, Treurnicht FK, et al
    Influenza viral shedding in a prospective cohort of HIV-infected and -uninfected children and adults in 2 provinces of South Africa, 2012-2014.
    J Infect Dis. 2018 May 24. pii: 5002738. doi: 10.1093.
    >> Share


  382. Erratum to Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.
    J Infect Dis. 2018 May 24. pii: 5003198. doi: 10.1093.
    >> Share

  383. DOBARD CW, Makarova N, West-Deadwyler R, Taylor A, et al
    Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal SHIV Exposures in Macaques.
    J Infect Dis. 2018 May 21. pii: 4999973. doi: 10.1093.
    >> Share

  384. LANGKILDE A, Tavenier J, Danielsen AV, Eugen-Olsen J, et al
    Histological and Molecular Adipose Tissue Changes are related to Metabolic Syndrome rather than Lipodystrophy in HIV-infected Patients-A Cross-Sectional Study.
    J Infect Dis. 2018 May 17. pii: 4997383. doi: 10.1093.
    >> Share

  385. TWISK DE, van der Sande MAB, van Eeden A, Heideman DAM, et al
    Detection of Incident Anal High-Risk Hpv-Dna in Msm: Incidence or Reactivation?
    J Infect Dis. 2018 May 16. pii: 4996623. doi: 10.1093.
    >> Share

  386. REICHLER MR, Khan A, Sterling TR, Zhao H, et al
    Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.
    J Infect Dis. 2018 May 15. pii: 4996045. doi: 10.1093.
    >> Share

  387. KOAY WLA, Lindsey JC, Uprety P, Bwakura-Dangarembizi M, et al
    Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.
    J Infect Dis. 2018 May 12. pii: 4995578. doi: 10.1093.
    >> Share

  388. NALWOGA A, Cose S, Nash S, Miley W, et al
    Relationship between Anaemia, Malaria Co-infection and Kaposi Sarcoma-associated Herpesvirus (KSHV) Seropositivity in a Population-based Study in Rural Uganda.
    J Infect Dis. 2018 May 8. pii: 4993751. doi: 10.1093.
    >> Share

  389. CHAN P, Patel P, Hellmuth J, Colby DJ, et al
    Distribution of HIV RNA in CSF and Blood is linked to CD4/CD8 Ratio During Acute HIV.
    J Infect Dis. 2018 May 7. pii: 4993332. doi: 10.1093.
    >> Share

  390. FARMAKI PF, Chini MC, Mangafas NM, Tzanoudaki MT, et al
    Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults.
    J Infect Dis. 2018 May 2. pii: 4990938. doi: 10.1093.
    >> Share

    April 2018
  391. SIEDNER MJ, Zanni M, Tracy RP, Kwon DS, et al
    Increased Systemic Inflammation and Gut Permeability Among Women with Treated HIV Infection in Rural Uganda.
    J Infect Dis. 2018 Apr 28. pii: 4989852. doi: 10.1093.
    >> Share

  392. KOSTAKI EG, Nikolopoulos GK, Pavlitina E, Williams L, et al
    Molecular analysis of HIV-1 infected individuals in a network-based intervention (TRIP): Phylogenetics identify HIV-1 infected individuals with social links.
    J Infect Dis. 2018 Apr 24. pii: 4984584. doi: 10.1093.
    >> Share

  393. COLBY DJ, Posuwan N, Kroon E, Phanuphak N, et al
    Reply to Chen et al.
    J Infect Dis. 2018 Apr 23. pii: 4982816. doi: 10.1093.
    >> Share

  394. HOSHINO A, Takashima T, Yoshida K, Morimoto A, et al
    Dysregulation of Epstein-Barr virus infection in hypomorphic ZAP70 mutation.
    J Infect Dis. 2018 Apr 19. pii: 4976509. doi: 10.1093.
    >> Share

  395. LIN KY, Hsieh SM, Sheng WH, Lo YC, et al
    Comparable serologic responses to 2 different combinations of inactivated HAV vaccines in HIV-positive patients during the acute hepatitis A outbreak in Taiwan.
    J Infect Dis. 2018 Apr 16. pii: 4972613. doi: 10.1093.
    >> Share

  396. BADEN LR, Walsh SR, Seaman MS, Cohen YZ, et al
    First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
    J Infect Dis. 2018 Apr 13. pii: 4969772. doi: 10.1093.
    >> Share

  397. REICHLER MR, Bangura J, Bruden D, Keimbe C, et al
    Household Transmission of Ebola Virus: risks and preventive factors, Freetown, Sierra Leone, 2015.
    J Infect Dis. 2018 Apr 6. pii: 4962469. doi: 10.1093.
    >> Share

  398. BRADLEY J, Floyd S, Piwowar-Manning E, Laeyendecker O, et al
    Sexually Transmitted Bedfellows: Exquisite Association between HIV and HSV2 in 21 Communities in Southern Africa in the HPTN 071 (PopART) Study.
    J Infect Dis. 2018 Apr 6. pii: 4962568. doi: 10.1093.
    >> Share

    March 2018
  399. PRINCIOTTO AM, Vrbanac VD, Melillo B, Park J, et al
    A Small-Molecule CD4-mimetic Compound Protects BLT Humanized Mice from Human Immunodeficiency Virus Infection.
    J Infect Dis. 2018 Mar 29. pii: 4956165. doi: 10.1093.
    >> Share

  400. PHAM HT, Labrie L, Wijting IEA, Hassounah S, et al
    The S230R Integrase Substitution Associated with Viral Rebound during DTG Monotherapy Confers Low Levels INSTI Drug Resistance.
    J Infect Dis. 2018 Mar 29. pii: 4956223. doi: 10.1093.
    >> Share

  401. WIJTING IEA, Lungu C, Rijnders BJA, van der Ende ME, et al
    HIV-1 resistance dynamics in patients failing dolutegravir maintenance monotherapy.
    J Infect Dis. 2018 Mar 29. pii: 4956224. doi: 10.1093.
    >> Share

  402. SCHUSTER C, Mayer FJ, Wohlfahrt C, Marculescu R, et al
    Acute HIV Infection Results in Subclinical Inflammatory Cardiomyopathy.
    J Infect Dis. 2018 Mar 28. pii: 4955987. doi: 10.1093.
    >> Share

  403. SSEMWANGA D, Doria-Rose NA, Redd AD, Shiakolas AR, et al
    Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.
    J Infect Dis. 2018 Mar 22. pii: 4932787. doi: 10.1093.
    >> Share

  404. POON AFY, Dearlove BL
    Quantifying the aftermath: Recent Outbreaks among People who in- ject Drugs and the Utility of Phylodynamics.
    J Infect Dis. 2018 Mar 13. pii: 4931170. doi: 10.1093.
    >> Share

  405. MURRAY LW, Satti I, Meyerowitz J, Jones M, et al
    Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell Responses.
    J Infect Dis. 2018 Mar 13. pii: 4932783. doi: 10.1093.
    >> Share

  406. RAGONNET-CRONIN M, Jackson C, Bradley-Stewart A, Aitken C, et al
    Recent and Rapid Transmission of HIV among People who Inject Drugs in Scotland Revealed through Phylogenetic Analysis.
    J Infect Dis. 2018 Mar 13. pii: 4931169. doi: 10.1093.
    >> Share

  407. STROUVELLE VP, Braun DL, Vongrad V, Scherrer AU, et al
    No Effect of Pegylated Interferon-alpha on Total Hiv-1 DNA Load in HIV-1/HCV Coinfected Patients.
    J Infect Dis. 2018 Mar 8. pii: 4924783. doi: 10.1093.
    >> Share

  408. THOMSON KA, Hughes J, Baeten JM, John-Stewart G, et al
    Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners.
    J Infect Dis. 2018 Mar 5. pii: 4915924. doi: 10.1093.
    >> Share

  409. STEFIC K, Novelli S, Mahjoub N, Seng R, et al
    Non-reactive HIV-1 Rapid Tests after Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection.
    J Infect Dis. 2018 Mar 2. pii: 4917573. doi: 10.1093.
    >> Share

    February 2018
  410. MOFENSON LM
    Risk of HIV Acquisition during Pregnancy and Postpartum: A Call for Action.
    J Infect Dis. 2018 Feb 28. pii: 4913312. doi: 10.1093.
    >> Share

  411. VOLZ EM, Le Vu S, Ratmann O, Tostevin A, et al
    Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control.
    J Infect Dis. 2018 Feb 26. pii: 4915980. doi: 10.1093.
    >> Share

  412. BAETEN JM
    Amplifying the Population Health Benefits of PrEP for HIV Prevention.
    J Infect Dis. 2018 Feb 26. pii: 4915988. doi: 10.1093.
    >> Share

  413. MARGOLICK JB, Bream JH, Nilles TL, Li H, et al
    Relationship Between T-Cell Responses to CMV, Markers of Inflammation, and Frailty in HIV-uninfected and HIV-infected Men in the Multicenter AIDS Cohort Study.
    J Infect Dis. 2018 Feb 26. pii: 4909741. doi: 10.1093.
    >> Share

  414. GANDHI M, Gandhi RT, Stefanescu A, Bosch RJ, et al
    Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.
    J Infect Dis. 2018 Feb 26. pii: 4848924. doi: 10.1093.
    >> Share

  415. RODRIGUEZ KM, Khalili J, Trevillian J, Currier J, et al
    What is the best model for HIV Primary Care? Assessing the influence of provider type on outcomes of chronic co-morbidities in HIV.
    J Infect Dis. 2018 Feb 22. pii: 4898101. doi: 10.1093.
    >> Share

  416. KOJIC EM, Conley L, Bush T, Cu-Uvin S, et al
    Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types covered by Current HPV Vaccines among HIV-Infected Women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study
    J Infect Dis. 2018 Feb 14. pii: 4857222. doi: 10.1093.
    >> Share

  417. KURODA MJ, Sugimoto C, Cai Y, Merino KM, et al
    High Turnover of Tissue Macrophages Contributes to Tuberculosis Reactivation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    J Infect Dis. 2018 Feb 8. pii: 4843840. doi: 10.1093.
    >> Share

  418. KHAN N, Divangahi M
    Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages.
    J Infect Dis. 2018 Feb 8. pii: 4843841. doi: 10.1093.
    >> Share

  419. UTAY NS, Kitch DW, Yeh E, Fichtenbaum CJ, et al
    Telmisartan Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued ART Alone.
    J Infect Dis. 2018 Feb 1. pii: 4833221. doi: 10.1093.
    >> Share

  420. SHANG L, Smith AJ, Duan L, Perkey KE, et al
    Vaccine-associated maintenance of epithelial integrity correlated with protection against virus entry.
    J Infect Dis. 2018 Feb 1. pii: 4833184. doi: 10.1093.
    >> Share

  421. BURBELO PD, Price RW, Hagberg L, Hatano H, et al
    Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
    J Infect Dis. 2018 Feb 1. pii: 4834093. doi: 10.1093.
    >> Share

  422. CLIFFORD DB
    Could We Harness Human Immunodeficiency Virus Antibodies to Monitor the Brain?
    J Infect Dis. 2018 Feb 1. pii: 4832662. doi: 10.1093.
    >> Share

    January 2018
  423. COMBES JD, Heard I, Poizot-Martin I, Canestri A, et al
    Prevalence and risk factors for anal human papillomavirus infection in HIV-positive men having sex with men.
    J Infect Dis. 2018 Jan 31. pii: 4830905. doi: 10.1093.
    >> Share

  424. ALLERS K, Kunkel D, Hofmann J, Stahl-Hennig C, et al
    Cell-associated SIV Accelerates Initial Virus Spread and CD4+ T cell Depletion in the Intestinal Mucosa.
    J Infect Dis. 2018 Jan 30. pii: 4829896. doi: 10.1093.
    >> Share

  425. WILSON P, Parr JB, Jhaveri R, Meshnick SR, et al
    Call to action: Prevention of mother-to-child transmission of hepatitis B in Africa.
    J Infect Dis. 2018 Jan 17. pii: 4812591. doi: 10.1093.
    >> Share

  426. COLLADO-DIAZ V, Andujar I, Sanchez-Lopez A, Orden S, et al
    Abacavir induces arterial thrombosis in a murine model.
    J Infect Dis. 2018 Jan 16. pii: 4810700. doi: 10.1093.
    >> Share

  427. PANDEY JP
    HIV-1 Control and Immunoglobulin Genes.
    J Infect Dis. 2018 Jan 15. pii: 4808592. doi: 10.1093.
    >> Share

  428. FONG Y, Shen X, Ashley VC, Deal A, et al
    Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505.
    J Infect Dis. 2018 Jan 8. pii: 4792964. doi: 10.1093.
    >> Share

  429. REID M, Ma Y, Scherzer R, Price JC, et al
    Contribution of liver fibrosis and microbial translocation to immune activation in HIV and HCV.
    J Infect Dis. 2018 Jan 3. pii: 4786614. doi: 10.1093.
    >> Share

    December 2017
  430. ANGELIDOU K, Hunt PW, Landay AL, Wilson CC, et al
    Changes in inflammation but not in T cell activation precede non-AIDS-defining events in a case-control study of patients on long-term antiretroviral therapy.
    J Infect Dis. 2017 Dec 22. pii: 4772233. doi: 10.1093.
    >> Share

  431. KOOIJ KW, Vogt L, Reiss P
    Reply to Moso et al.
    J Infect Dis. 2017 Dec 22. pii: 4772651. doi: 10.1093.
    >> Share

  432. MOSO MA, Woolnough E, Langham F, Hoy JF, et al
    Increasing prevalence and risk of chronic kidney disease in HIV-positive individuals: changing demographics over a six-year period.
    J Infect Dis. 2017 Dec 22. pii: 4772637. doi: 10.1093.
    >> Share

  433. TANSEY C, Zhao C, Hopkins A, Ritter JM, et al
    A Non-human Primate Model for Rectally Transmitted Syphilis.
    J Infect Dis. 2017 Dec 22. pii: 4772175. doi: 10.1093.
    >> Share

  434. GIBBS A, Buggert M, Edfeldt G, Ranefall P, et al
    HIV-infected women have high numbers of CD103-CD8+ T cells residing close to the basal membrane of the ectocervical epithelium.
    J Infect Dis. 2017 Dec 20. pii: 4767924. doi: 10.1093.
    >> Share

  435. SHIELS MS, Kirk GD, Drummond MB, Dhillon D, et al
    HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.
    J Infect Dis. 2017 Dec 19. pii: 4762465. doi: 10.1093.
    >> Share

  436. WALLENDER E, Vucicevic K, Jagannathan P, Huang L, et al
    Predicting optimal dihydroartemisinin-piperaquine regimens to prevent malaria during pregnancy for HIV-infected women receiving efavirenz.
    J Infect Dis. 2017 Dec 19. pii: 4762345. doi: 10.1093.
    >> Share

  437. GALLANT J, Hsue PY, Shreay S, Meyer N, et al
    Comorbidities Among US Patients With Prevalent HIV Infection-A Trend Analysis.
    J Infect Dis. 2017;216:1525-1533.
    >> Share

  438. VAN DER VALK M, Reiss P
    Noncommunicable Diseases in People Living With HIV: Time for Integrated Care.
    J Infect Dis. 2017;216:1481-1483.
    >> Share

  439. BOPPANA SB, Britt WJ, Fowler K, Hutto SC, et al
    Pathogenesis of Non-Zika Congenital Viral Infections.
    J Infect Dis. 2017;216.
    >> Share

  440. GREGORY CJ, Oduyebo T, Brault AC, Brooks JT, et al
    Modes of Transmission of Zika Virus.
    J Infect Dis. 2017;216.
    >> Share

  441. SIEDNER MJ, Hunt PW
    All About the Albumin? Prognostic Capacity of Serum Albumin in Patients With Treated HIV Infection.
    J Infect Dis. 2017 Dec 13. pii: 4736315. doi: 10.1093.
    >> Share

  442. RONIT A, Sharma S, Baker JV, Mngqibisa R, et al
    Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study.
    J Infect Dis. 2017 Dec 13. pii: 4736314. doi: 10.1093.
    >> Share

  443. KING CC, Ellington SR, Davis NL, Coombs RW, et al
    Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy.
    J Infect Dis. 2017 Dec 12. pii: 4733301. doi: 10.1093.
    >> Share

  444. HAYASHI K, Dong H, Kerr T, Dobrer S, et al
    Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.
    J Infect Dis. 2017 Dec 12. pii: 4731720. doi: 10.1093.
    >> Share

  445. SIVRO A, McKinnon LR
    Mucosal HIV Shedding During ART.
    J Infect Dis. 2017 Dec 12. pii: 4733302. doi: 10.1093.
    >> Share

  446. RANGANATH N, Sandstrom TS, Burke Schinkel SC, Cote SC, et al
    The oncolytic virus, MG1, targets and eliminates latently HIV-1-infected cells: implications for an HIV cure.
    J Infect Dis. 2017 Dec 8. pii: 4706282. doi: 10.1093.
    >> Share

  447. AJAYKUMAR A, Soudeyns H, Kakkar F, Brophy J, et al
    Leukocyte telomere length at birth and during the early life of HIV-exposed uninfected children following in utero exposure to antiretrovirals.
    J Infect Dis. 2017 Dec 8. pii: 4706016. doi: 10.1093.
    >> Share

  448. NYITRAY AG, Fujimoto K, Zhao J, Giuliano AR, et al
    Prevalence of and risk factors for anal HPV among a sample of predominantly black men who have sex with men in Houston, Texas.
    J Infect Dis. 2017 Dec 5. pii: 4690591. doi: 10.1093.
    >> Share

  449. PATEL P, Bush T, Kojic EM, Conley L, et al
    Prevalence, incidence, and clearance of anal high-risk human papillomavirus (HPV) infection among HIV-infected men in the SUN Study.
    J Infect Dis. 2017 Dec 4. pii: 4689803. doi: 10.1093.
    >> Share

  450. STELLA-ASCARIZ N, Arribas JR, Paredes R, Li JZ, et al
    The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.
    J Infect Dis. 2017;216.
    >> Share

  451. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.
    J Infect Dis. 2017;216.
    >> Share

  452. RAIZES E, Hader S, Birx D
    Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
    J Infect Dis. 2017;216.
    >> Share

    November 2017
  453. MAKVANDI-NEJAD S, Laurenson-Schafer H, Wang L, Wellington D, et al
    Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
    J Infect Dis. 2017 Nov 30. pii: 4676001. doi: 10.1093.
    >> Share

  454. ANDREI G, Gillemot S, Topalis D, Snoeck R, et al
    The anti-HIV drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus (HSV) DNA polymerase.
    J Infect Dis. 2017 Nov 23. pii: 4653578. doi: 10.1093.
    >> Share

  455. BOON D, Redd AD, Layendecker O, Engle R, et al
    Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda.
    J Infect Dis. 2017 Nov 23. pii: 4653785. doi: 10.1093.
    >> Share

  456. JUSTICE AC, Erlandson KM, Miotti PG, Landay A, et al
    Can Biomarkers Advance HIV Research and Care in the ART Era?
    J Infect Dis. 2017 Nov 20. doi: 10.1093.
    >> Share

  457. CHAUDHURY CS, Sheehan J, Chairez C, Akoth E, et al
    No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.
    J Infect Dis. 2017 Nov 17. doi: 10.1093.
    >> Share

  458. BUTI M, Riveiro-Barciela M, Esteban R
    Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection.
    J Infect Dis. 2017;216.
    >> Share

  459. YEN YF, Lan YC, Huang CT, Jen IA, et al
    Human Immunodeficiency Virus Infection Increases the Risk of Incident Autoimmune Hemolytic Anemia: A Population-Based Cohort Study in Taiwan.
    J Infect Dis. 2017;216:1000-1007.
    >> Share

  460. HUANG YA, Tao G, Samandari T, Hoover KW, et al
    Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
    J Infect Dis. 2017 Nov 14. doi: 10.1093.
    >> Share

  461. STEBA GS, Koekkoek SM, Vanhommerig JW, Brinkman K, et al
    DC-SIGN Polymorphisms Associated with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.
    J Infect Dis. 2017 Nov 13. doi: 10.1093.
    >> Share

  462. REID MJA, Goosby E
    Patient-Centered Tuberculosis Programs Are Necessary to End the Epidemic.
    J Infect Dis. 2017;216.
    >> Share

  463. NAIDOO P, Theron G, Rangaka MX, Chihota VN, et al
    The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.
    J Infect Dis. 2017;216.
    >> Share

  464. CHURCHYARD G, Kim P, Shah NS, Rustomjee R, et al
    What We Know About Tuberculosis Transmission: An Overview.
    J Infect Dis. 2017;216.
    >> Share

  465. MATHEMA B, Andrews JR, Cohen T, Borgdorff MW, et al
    Drivers of Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    >> Share

  466. AULD SC, Kasmar AG, Dowdy DW, Mathema B, et al
    Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
    J Infect Dis. 2017;216.
    >> Share

  467. SHAH NS, Kim P, Kana BD, Rustomjee R, et al
    Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    >> Share

  468. NEWTON R, Labo N, Wakeham K, Miley W, et al
    Kaposi's sarcoma associated herpesvirus in a rural Ugandan cohort: 1992-2008.
    J Infect Dis. 2017 Nov 1. doi: 10.1093.
    >> Share

    October 2017
  469. VAN ZOEST RA, Underwood J, De Francesco D, Sabin CA, et al
    Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
    J Infect Dis. 2017 Oct 24. doi: 10.1093.
    >> Share

  470. SIBERRY GK, Amzel A, Ramos A, Rivadeneira ED, et al
    Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.
    J Infect Dis. 2017 Oct 17. doi: 10.1093.
    >> Share

  471. KIRKEGAARD-KLITBO DM, Langkilde A, Mejer N, Andersen O, et al
    Soluble Urokinase Plasminogen Activator Receptor Is a Predictor of Incident Non-AIDS Comorbidity and All-Cause Mortality in Human Immunodeficiency Virus Type 1 Infection.
    J Infect Dis. 2017;216:819-823.
    >> Share

  472. LI G, Nunoya JI, Cheng L, Reszka-Blanco N, et al
    Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4 T Cells Through cAMP-Dependent Mechanisms in Humanized Mice In Vivo.
    J Infect Dis. 2017 Oct 14. doi: 10.1093.
    >> Share

  473. BERTAGNOLIO S, Beanland RL, Jordan MR, Doherty M, et al
    The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    >> Share

  474. DUARTE HA, Panpradist N, Beck IA, Lutz B, et al
    Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    >> Share

  475. PINTYE J, Baeten JM, Celum C, Mugo N, et al
    Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: a prospective study.
    J Infect Dis. 2017 Oct 10. doi: 10.1093.
    >> Share

  476. SILVERMAN RA, Beck IA, Kiptinness C, Levine M, et al
    Prevalence of Pre-antiretroviral Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-infected Individuals Initiating Therapy in Kenya, 2013-2014.
    J Infect Dis. 2017 Oct 10. doi: 10.1093.
    >> Share

  477. NGOBENI R, Samie A, Moonah S, Watanabe K, et al
    Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia.
    J Infect Dis. 2017 Oct 8. pii: 4372272. doi: 10.1093.
    >> Share

  478. ROH ME, Shiboski S, Natureeba P, Kakuru A, et al
    Protective effect of indoor residual spraying of insecticide on preterm birth among pregnant women with HIV in Uganda: A secondary data analysis.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  479. MINIOR T, Douglas M, Edgil D, Srivastava M, et al
    The Critical Role of Supply Chains in Preventing Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Settings.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  480. ZHUKOVA A, Cutino-Moguel T, Gascuel O, Pillay D, et al
    The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  481. SINGH D, Dhummakupt A, Siems L, Persaud D, et al
    Alternative Sample Types for HIV-1 Antiretroviral Drug Resistance Testing.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  482. PARASKEVIS D
    Investigation of Human Immunodeficiency Virus Outbreaks Among People Who Inject Drugs: Timely Diagnosis and Molecular Surveillance are Crucial.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  483. CHUN HM, Obeng-Aduasare YF, Broyles LN, Ellenberger D, et al
    Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  484. BUNJUN R, Riou C, Soares AP, Thawer N, et al
    Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  485. CAMPBELL EM, Jia H, Shankar A, Hanson D, et al
    Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  486. DONAHUE CARLSON R, Sheth AN, Read TD, Frisch MB, et al
    The Female Genital Tract Microbiome Is Associated With Vaginal Antiretroviral Drug Concentrations in Human Immunodeficiency Virus-Infected Women on Antiretroviral Therapy.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

    September 2017
  487. BORRE ED, Hyle EP, Paltiel AD, Neilan AM, et al
    The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.
    J Infect Dis. 2017 Sep 28. doi: 10.1093.
    >> Share

  488. ADIMORA AA
    Implementing National HIV/AIDS Strategy 2015 Treatment Targets Is Cost-effective and Would Save Lives: What Other Evidence Do We Need?
    J Infect Dis. 2017 Sep 28. doi: 10.1093.
    >> Share

  489. PRENDERGAST AJ, Chasekwa B, Rukobo S, Govha M, et al
    Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants.
    J Infect Dis. 2017;216:651-661.
    >> Share

  490. FOLDI J, Kozhaya L, McCarty B, Mwamzuka M, et al
    HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.
    J Infect Dis. 2017;216:641-650.
    >> Share

  491. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis. 2017;216:632-640.
    >> Share

  492. KOOIJ KW, Vogt L, Wit FWNM, van der Valk M, et al
    Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    J Infect Dis. 2017;216:622-631.
    >> Share

  493. MOORE T, Dembry LM, Saag MS
    Sunday in the Park with Infectious Disease: Workforce Mismatch in a Colorful Universe of Possibilities.
    J Infect Dis. 2017;216.
    >> Share

  494. GALLANT JE
    Human Immunodeficiency Virus Medicine.
    J Infect Dis. 2017;216.
    >> Share

  495. PIROFSKI LA
    Life as an Infectious Diseases Physician Scientist: Science is Humanity's Lifeline.
    J Infect Dis. 2017;216.
    >> Share

  496. DEL RIO C
    From Trained Infectious Diseases Clinician to Global Health Leader, Reflections on the Last 30 Years.
    J Infect Dis. 2017;216.
    >> Share

  497. NOGUERA-JULIAN M, Edgil D, Harrigan PR, Sandstrom P, et al
    Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.
    J Infect Dis. 2017 Sep 15. doi: 10.1093.
    >> Share

  498. GODFREY C, Bobkova M, Boucher C, Ravasi G, et al
    Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    >> Share

  499. CHIKATA T, Murakoshi H, Koyanagi M, Honda K, et al
    Control of HIV-1 by an HLA-B*52:01-C*12:02 protective haplotype.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    >> Share

  500. MCLAREN PJ, Pulit SL, Gurdasani D, Bartha I, et al
    Evaluating the impact of functional genetic variation on HIV-1 control.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    >> Share

  501. LIU Y, Gaisa MM, Wang X, Swartz TH, et al
    Immune Microenvironments of Anal Cancer Precursors Differ by HIV-serostatus, Affecting Ablation Outcomes.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    >> Share

  502. NING T, Wolfe A, Nie J, Huang W, et al
    Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    >> Share

  503. AKE JA, Schuetz A, Pegu P, Wieczorek L, et al
    Safety and Immunogenicity of PENNVAX(R)-G DNA Prime Administered by Biojector(R) 2000 or CELLECTRA(R) Electroporation Device with Modified Vaccinia Ankara-CMDR Boost.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    >> Share

  504. SMITH B
    Toward Understanding the When and Why of Human Immunodeficiency Virus-Associated Stroke.
    J Infect Dis. 2017;216:509-510.
    >> Share

  505. BENJAMIN LA, Allain TJ, Mzinganjira H, Connor MD, et al
    The Role of Human Immunodeficiency Virus-Associated Vasculopathy in the Etiology of Stroke.
    J Infect Dis. 2017;216:545-553.
    >> Share

  506. MOLLAN KR, Tierney C, Hellwege JN, Eron JJ, et al
    Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.
    J Infect Dis. 2017;216:554-564.
    >> Share

    August 2017
  507. WEITZMANN MN, Vikulina T, Roser-Page S, Yamaguchi M, et al
    Homeostatic Expansion of CD4+ T-cells Promotes Cortical and Trabecular Bone Loss while CD8+ T-cells Induce Trabecular Bone Loss Only.
    J Infect Dis. 2017 Aug 25. doi: 10.1093.
    >> Share

  508. ASMUTH DM, Thompson CG, Chun TW, Ma ZM, et al
    Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal GALT Immune Reconstitution in HIV-infected Patients Initiating Antiretroviral Therapy.
    J Infect Dis. 2017 Aug 23. doi: 10.1093.
    >> Share

  509. BOEIJEN LL, Montanari NR, de Groen RA, van Oord GW, et al
    Mucosal-associated invariant T (MAIT) cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy.
    J Infect Dis. 2017 Aug 23. doi: 10.1093.
    >> Share

  510. DE POKOMANDY A, Kaufman E, de Castro C, Mayrand MH, et al
    The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
    J Infect Dis. 2017;216:447-456.
    >> Share

  511. CRABTREE KL, Wojcicki JM, Minhas V, Kankasa C, et al
    Food and Drink Sharing in the Household are Associated with HHV-8 Seroconversion in a Cohort of Zambian Children.
    J Infect Dis. 2017 Aug 14. doi: 10.1093.
    >> Share

    June 2017
  512. GODFREY C, Thigpen MC, Crawford KW, Jean-Phillippe P, et al
    Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016